hepg2-stable cell line growth Search Results


hepg2  (ATCC)
99
ATCC hepg2
Fig. 2. ROR Activates Transcription through the (355/366) RORE of the Fibrinogen- Promoter A, <t>HepG2</t> <t>human</t> <t>hepatoma</t> <t>cells</t> were cotransfected with 500 ng of the p(FibRORE)4x-Tk-Luc luciferase reporter vector or with 500 ng of the pTk-Luc control vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. B, HepG2 cells were cotransfected with 500 ng of the phFib-Luc luciferase reporter vector carrying either the (400 to 13) or the truncated (258 to 13) region of the human fibrinogen- promoter or with 500 ng of the phFibmut-Luc mutated vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. C, HepG2 cells were cotransfected with 500 ng of the phFib-Luc or of the phFib-mut-Luc luciferase reporter vector carrying either the wild-type (400 to 13) or the mutated region of the human fibrinogen- promoter, respectively, and 666 ng of the empty pCMX vector () or of the pCMX-hROR1 () expression vector. In all cases, the luciferase activity of the vectors in the presence of the pCMX-hROR1 expression vector was expressed relative to that in the absence of expression vector. Results are given as means SEM (n 6).
Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/Hep+G2/pm15941850-166-0-6
Average 99 stars, based on 1 article reviews
hepg2 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

90
JCRB Cell Bank huh-7
Fig. 2. ROR Activates Transcription through the (355/366) RORE of the Fibrinogen- Promoter A, <t>HepG2</t> <t>human</t> <t>hepatoma</t> <t>cells</t> were cotransfected with 500 ng of the p(FibRORE)4x-Tk-Luc luciferase reporter vector or with 500 ng of the pTk-Luc control vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. B, HepG2 cells were cotransfected with 500 ng of the phFib-Luc luciferase reporter vector carrying either the (400 to 13) or the truncated (258 to 13) region of the human fibrinogen- promoter or with 500 ng of the phFibmut-Luc mutated vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. C, HepG2 cells were cotransfected with 500 ng of the phFib-Luc or of the phFib-mut-Luc luciferase reporter vector carrying either the wild-type (400 to 13) or the mutated region of the human fibrinogen- promoter, respectively, and 666 ng of the empty pCMX vector () or of the pCMX-hROR1 () expression vector. In all cases, the luciferase activity of the vectors in the presence of the pCMX-hROR1 expression vector was expressed relative to that in the absence of expression vector. Results are given as means SEM (n 6).
Huh 7, supplied by JCRB Cell Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/hepg2+cells/pm40005578-40-10-5
Average 90 stars, based on 1 article reviews
huh-7 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology hepg2 cells
( A ) Transcriptional levels of the avpr1b in hypothalamus, pancreas, jejunum, kidney, liver, and spleen of WT mice on water Ctrl (clear purple bars) or receiving a 10% Frct solution for 30 weeks (solid purple bars). ( B ) Transcriptional levels of the avpr1a (red line) and the avpr1b (purple line) in liver of WT mice receiving a 10% Frct solution for 30 weeks. ( C and D ) Representative Western blot and densitometry ( n = 2 total blots) for the V1bR, fructokinase (KHK), and actin in human <t>HepG2</t> cells Ctrl or exposed to AVP (250 nM), Frct (10 mM), or a combination of Frct plus AVP for 5 days. ( E ) KHK activity in HepG2 lysates from Ctrl, AVP, Frct, and Frct plus AVP cells. ( F ) Representative Western blot and densitometry ( n = 2 total blots) for V1bR and actin in HepG2 transduced with noncodifying shRNA ( scr ) or shRNA against avpr1b ( shAvpr1b ) at baseline or a Frct (10 mM) exposure. ( G ) Representative Western blot and densitometry ( n = 2 total blots) for KHK and actin in Ctrl, AVP, Frct, and Frct plus AVP HepG2 cells stably silenced for V1bR expression. ( H and I ) Representative Western blot ( n = 2 total blots) and densitometry for KHK, actin, and lipogenic enzymes FAS and ACC in the liver of WT and V1bR-KO mice on water Ctrl or receiving a 10% Frct solution for 30 weeks. The data in A and C–E are presented as the mean ± SD and analyzed by 1-way ANOVA with Tukey’s post hoc analysis. * P < 0.05, ** P < 0.01. For A and B and E , n = 6 mice per group. For C – E , n = 2 independent cultured plates. V1bR, vasopressin 1b receptor; avpr1b , vasopressin 1b receptor gene; avpr1a , vasopressin 1a receptor gene; KHK, ketohexokinase; Ctrl, control; AVP, vasopressin; Frct, fructose; scr , scramble; FAS, fatty acid synthase; ACC, acetyl-CoA carboxylase.
Hepg2 Cells, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/Hep+G2+Cell+Lysate/pmc07821599-164-3-18
Average 94 stars, based on 1 article reviews
hepg2 cells - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

99
ATCC human hepatoblastoma cell line hepg2
FIG. 6. Liver histology of a <t>HepG2-hIL-6R</t> tumor that developed 1 month following intrasplenic injection into a SCID . BNX chimeric mice (H & E staining).
Human Hepatoblastoma Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/Hep+G2%3B+Hepatocellular%3B+Carcinoma%3B+Human/pm10792989-197-12-17
Average 99 stars, based on 1 article reviews
human hepatoblastoma cell line hepg2 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
DSMZ hepg2 human hepatoma cells
Diethyl maleate stimulates Nrf2 but not FOXO-dependent gene expression. <t>HepG2</t> cells were exposed to DEM (1 mM) for 4 h or 16 h in serum-free DMEM (A) , followed by analysis of G6PC and SELENOP mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. (B) HepG2 cells, grown to approx. 75% confluence, were held on serum-free medium for 18 h, followed by exposure to DEM at the given concentrations for 2 h. If indicated, this was followed by a 30 min incubation with insulin (100 nM). Nuclear extracts were prepared and binding of endogenous FOXO1 to an oligonucleotide containing FOXO binding elements analyzed in an ELISA-based approach. Data are means of three independent experiments + SD. (C) HepG2 cells were exposed to DEM for 4 h or 16 h, followed by analysis of Nrf2 target gene mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. Statistical significance was assessed using Student's t -test: *P < 0.05, **P < 0.01 vs. respective control.
Hepg2 Human Hepatoma Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/HEP-G2/pmc06156746-40-0-21
Average 96 stars, based on 1 article reviews
hepg2 human hepatoma cells - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Puracyp Inc dpx2 cells
(A) Quantification of BDP metabolites produced by A549 cells treated with BDP or BDP with esterase inhibitors (+EI). (B) Relative quantification of BDP metabolites produced by <t>DPX2</t> cells treated with BDP or BDP with esterase inhibitors (+EI). Data are the mean and standard deviation from six replicates. n.d. Signifies that the metabolite was not detected. (C and D) <t>CYP3A</t> enzyme mRNA abundance, measured by qPCR in A549 (C) and DPX2 (D) cells. Data are represented as the number of mRNA copies per 10,000 copies of β2-macroglobulin (a “housekeeping” gene). Statistics used for A549 cell data analysis were one-way analysis of variance with Dunnett’s post-hoc test. For DPX2 cell data analysis two-way ANOVA with Bonferronni post-hoc testing was used. Data are the mean and standard deviation from 6 replicates. n.d. Signifies that mRNA was not detected. *P < 0.05; ***P < 0.001; ****P < 0.0001.
Dpx2 Cells, supplied by Puracyp Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/dpx2+cells/pmc03629798-86-0-28
Average 90 stars, based on 1 article reviews
dpx2 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
Thermo Fisher hepg2 cells
(A) Expression of GREB1, TFF1, and WISP-2 by qPCR analysis in <t>HepG2</t> cells stably expressing WT or ERα-Q375H treated with vehicle or the indicated concentrations of E2. The samples (n = 4) were normalized to human ACTB expression. The fold changes by log2 transform were calculated relative to the HepG2/WT ERα vehicle ± SEM, using the two-way ANOVA with Tukey’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, or ****P < 0.0001). (B) Comparisons of protein interactomes of WT ERα and ERα-Q375H (QH) ERα. Venn diagrams show unliganded interactions and liganded interactions. The interactions unique to WT and ERα-Q375H are listed. (C) Interactions of ERα, GREB1, HDAC1, and GADD45G with WT ERα or Q375H mutant ERα by RIME analysis of chromatin extracts from HepG2 cells stably expressing WT or ERα-Q375H and treated with vehicle or 10 nM E2. RIME assay was carried out using an ERα antibody to identify the proteins that interacted with ERα using mass spectrometry.
Hepg2 Cells, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/Phenol+Red/pmc07597377-502-0-11
Average 99 stars, based on 1 article reviews
hepg2 cells - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
Proteintech glut1 antibody
Excess glucose availability promotes <t>GLUT1</t> clearance from the plasma membrane (A) HeLa cells were cultured for 24 h in media with no glucose, then switched to high glucose media (25 mM) for the indicated amount of time. Biotin-labeling was performed at the post-glucose shift time points. Following biotinylation, labeled cells were lysed and surface proteins were affinity purified with NeutrAvidin beads (Thermo Scientific). Analysis was performed by SDS-PAGE and immunoblot with antibodies that recognize GLUT1, Na + /K + ATPase, and GAPDH. (B,C) Quantification of captured GLUT1 (B) and Na + /K + ATPase (C) for the experiment shown in (A) was performed over multiple biological replicates (n ≥ 3). GLUT1 measurements were taken of the whole lane using FIJI. Immunoblots for biological replicate experiments are provided in . (D) HeLa cells stably expressing mCherry-CaaX (red) were cultured in no glucose media for 24 h (top row) then shifted to high glucose (25 mM) for 24 h (bottom row), at which point the samples were fixed for immunofluorescence detection with GLUT1 antibody (green). Zoomed images provided in the far right column correspond to the yellow dashed-line inset boxes in the
Glut1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/GLUT1+Antibody/pmc09986520-9-0-3
Average 96 stars, based on 1 article reviews
glut1 antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Shenogen Pharma Group Ltd human hcc huh7 cell line
Excess glucose availability promotes <t>GLUT1</t> clearance from the plasma membrane (A) HeLa cells were cultured for 24 h in media with no glucose, then switched to high glucose media (25 mM) for the indicated amount of time. Biotin-labeling was performed at the post-glucose shift time points. Following biotinylation, labeled cells were lysed and surface proteins were affinity purified with NeutrAvidin beads (Thermo Scientific). Analysis was performed by SDS-PAGE and immunoblot with antibodies that recognize GLUT1, Na + /K + ATPase, and GAPDH. (B,C) Quantification of captured GLUT1 (B) and Na + /K + ATPase (C) for the experiment shown in (A) was performed over multiple biological replicates (n ≥ 3). GLUT1 measurements were taken of the whole lane using FIJI. Immunoblots for biological replicate experiments are provided in . (D) HeLa cells stably expressing mCherry-CaaX (red) were cultured in no glucose media for 24 h (top row) then shifted to high glucose (25 mM) for 24 h (bottom row), at which point the samples were fixed for immunofluorescence detection with GLUT1 antibody (green). Zoomed images provided in the far right column correspond to the yellow dashed-line inset boxes in the
Human Hcc Huh7 Cell Line, supplied by Shenogen Pharma Group Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/human+hcc+hepg2+cell+line/pm39718681-53-3-16
Average 90 stars, based on 1 article reviews
human hcc huh7 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection hepg2.2.15 cells (with stable expression and replication of hbv)
Phospholipids analysis of <t>HepG2</t> and <t>HepG2.2.15</t> cells. ( A ) OPLS-DA scores plots showing the separation between HepG2 and HepG2.2.15 cells, Q 2 = 0.902, p = 1.90 × 10 −6 . ( B ) The total amount of each class of phospholipid in cells. ( C ) The significant difference of phospholipids between HepG2 and HepG2.2.15 cells. The significance of the metabolites was used the criteria that variable VIP > 1, p value < 0.05, and fold change > 1.2 or < 0.8. The histogram is expressed as mean ± SD, n = 10, detailed data of phosphatidylcholines are shown in Table . *** p value < 0.001, ** p value < 0.01, * p value < 0.05.
Hepg2.2.15 Cells (With Stable Expression And Replication Of Hbv), supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/hepg2+cells/pmc06736851-140-7-19
Average 90 stars, based on 1 article reviews
hepg2.2.15 cells (with stable expression and replication of hbv) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Addgene inc hepg2 gr
Lys 154 is the major Dex-induced acetylation site (A) Western blot analysis with pan acetyl-lysine (ac-K) detecting acetylation levels of the FLAG-tagged GR-wild-type (WT) or Lys to Arg mutants of the individual AF-1 acetylation sites, all three (τ1-KR), and all seven residues in the NTD (7KR), immunoprecipitated from BHK-21 cells that were treated with vehicle or 1 μM Dex for 6 h. (B) Scheme indicating position of the acetylated lysines in the N-terminal domain of hGR. Lys 154 is marked in red and its conservation among murine, rat, bovine and human GR is shown in the multiple sequence alignment below. Color scheme indicating amino acid properties and consensus symbols is as outlined by CLUSTAL Omega. (C) Western blot detection of global GR acetylation with pan acetyl-lysine antibody or GR-K154 acetylation with the site-specific anti-acK154 antibodies in FLAG immunoprecipitates (top:IP) and whole cell lysates (bottom) prepared from HEK293 GR −/− cells transiently expressing wild-type or mutant FLAG-GR and treated with vehicle or 1 μM Dex for 6 h. (D) Western blot monitoring endogenous GR-K154 acetylation in lysates from vehicle or Dex (1 μM, 6 h) treated human <t>(HepG2,</t> A549 and HeLa), primary human umbilical vein endothelial cells (HUVEC) and mouse fibroblast (NIH3T3) cell lines. Beta actin (ACTB) served as loading control. (E) Western blot analysis of GR-K154 acetylation in tissue lysates derived from liver, lung and spleen of C57BL/6 mice treated with vehicle or 1 mg/kg Dex (i.p) for 6 h. Vinculin (VCL) served as loading control. (F) Immunoblot of GR-K154 acetylation in vehicle- or Dex- (1 μM, 6 h) treated HepG2 cells that were co-treated with DMSO (as control), 20 μM Ex527 or 5 μM A485 respectively. (G) Ratios of acK154 to GR western blot signals from (F) were quantified and normalized to Dex+DMSO sample and represented as relative acK154/GR (Mean ± S.E.M; n = 3 independent experiments, ∗p < 0.05, ∗∗p < 0.01; Welch’s t-test). See also <xref ref-type=Figure S2 . " width="250" height="auto" />
Hepg2 Gr, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/pLenti6%2FUbC%2FmSlc7a1+(Plasmid+%2317224)/pmc10850750-348-0-8
Average 93 stars, based on 1 article reviews
hepg2 gr - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

97
Qiagen rneasy kit
Lys 154 is the major Dex-induced acetylation site (A) Western blot analysis with pan acetyl-lysine (ac-K) detecting acetylation levels of the FLAG-tagged GR-wild-type (WT) or Lys to Arg mutants of the individual AF-1 acetylation sites, all three (τ1-KR), and all seven residues in the NTD (7KR), immunoprecipitated from BHK-21 cells that were treated with vehicle or 1 μM Dex for 6 h. (B) Scheme indicating position of the acetylated lysines in the N-terminal domain of hGR. Lys 154 is marked in red and its conservation among murine, rat, bovine and human GR is shown in the multiple sequence alignment below. Color scheme indicating amino acid properties and consensus symbols is as outlined by CLUSTAL Omega. (C) Western blot detection of global GR acetylation with pan acetyl-lysine antibody or GR-K154 acetylation with the site-specific anti-acK154 antibodies in FLAG immunoprecipitates (top:IP) and whole cell lysates (bottom) prepared from HEK293 GR −/− cells transiently expressing wild-type or mutant FLAG-GR and treated with vehicle or 1 μM Dex for 6 h. (D) Western blot monitoring endogenous GR-K154 acetylation in lysates from vehicle or Dex (1 μM, 6 h) treated human <t>(HepG2,</t> A549 and HeLa), primary human umbilical vein endothelial cells (HUVEC) and mouse fibroblast (NIH3T3) cell lines. Beta actin (ACTB) served as loading control. (E) Western blot analysis of GR-K154 acetylation in tissue lysates derived from liver, lung and spleen of C57BL/6 mice treated with vehicle or 1 mg/kg Dex (i.p) for 6 h. Vinculin (VCL) served as loading control. (F) Immunoblot of GR-K154 acetylation in vehicle- or Dex- (1 μM, 6 h) treated HepG2 cells that were co-treated with DMSO (as control), 20 μM Ex527 or 5 μM A485 respectively. (G) Ratios of acK154 to GR western blot signals from (F) were quantified and normalized to Dex+DMSO sample and represented as relative acK154/GR (Mean ± S.E.M; n = 3 independent experiments, ∗p < 0.05, ∗∗p < 0.01; Welch’s t-test). See also <xref ref-type=Figure S2 . " width="250" height="auto" />
Rneasy Kit, supplied by Qiagen, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2-stable+cell+line+growth/RNeasy+96+Kit/pm37175827-255-16-15
Average 97 stars, based on 1 article reviews
rneasy kit - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

Image Search Results


Fig. 2. ROR Activates Transcription through the (355/366) RORE of the Fibrinogen- Promoter A, HepG2 human hepatoma cells were cotransfected with 500 ng of the p(FibRORE)4x-Tk-Luc luciferase reporter vector or with 500 ng of the pTk-Luc control vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. B, HepG2 cells were cotransfected with 500 ng of the phFib-Luc luciferase reporter vector carrying either the (400 to 13) or the truncated (258 to 13) region of the human fibrinogen- promoter or with 500 ng of the phFibmut-Luc mutated vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. C, HepG2 cells were cotransfected with 500 ng of the phFib-Luc or of the phFib-mut-Luc luciferase reporter vector carrying either the wild-type (400 to 13) or the mutated region of the human fibrinogen- promoter, respectively, and 666 ng of the empty pCMX vector () or of the pCMX-hROR1 () expression vector. In all cases, the luciferase activity of the vectors in the presence of the pCMX-hROR1 expression vector was expressed relative to that in the absence of expression vector. Results are given as means SEM (n 6).

Journal: Molecular endocrinology (Baltimore, Md.)

Article Title: The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.

doi: 10.1210/me.2005-0153

Figure Lengend Snippet: Fig. 2. ROR Activates Transcription through the (355/366) RORE of the Fibrinogen- Promoter A, HepG2 human hepatoma cells were cotransfected with 500 ng of the p(FibRORE)4x-Tk-Luc luciferase reporter vector or with 500 ng of the pTk-Luc control vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. B, HepG2 cells were cotransfected with 500 ng of the phFib-Luc luciferase reporter vector carrying either the (400 to 13) or the truncated (258 to 13) region of the human fibrinogen- promoter or with 500 ng of the phFibmut-Luc mutated vector and increasing amounts (0, 166, 333, or 666 ng) of pCMX-hROR1 expression vector while keeping the total amount of transfected DNA constant to 1166 ng by adding the pCMX insertless vector. C, HepG2 cells were cotransfected with 500 ng of the phFib-Luc or of the phFib-mut-Luc luciferase reporter vector carrying either the wild-type (400 to 13) or the mutated region of the human fibrinogen- promoter, respectively, and 666 ng of the empty pCMX vector () or of the pCMX-hROR1 () expression vector. In all cases, the luciferase activity of the vectors in the presence of the pCMX-hROR1 expression vector was expressed relative to that in the absence of expression vector. Results are given as means SEM (n 6).

Article Snippet: HepG2 and Hep3B human hepatoma cells (American Type Culture Collection, Manassas, VA; HB-8065 and HB-8064, respectively) were cultured in a 1:1 mixture of DMEM and Ham-F12 media with Glutamax-I, supplemented with 10% (vol/vol) fetal bovine serum, 100 g/ml gentamycin, and 2.5 g/ml fungizone (all from Invitrogen, San Diego, CA) as previously described (24).

Techniques: Luciferase, Plasmid Preparation, Control, Expressing, Transfection, Activity Assay

Fig. 3. Stably Transfected HepG2 and Hep3B Hepatoma Cells Overexpressing ROR Have Higher Fibrinogen- mRNA Levels HepG2 and Hep3B human hepatoma cells were stably transfected with the pCMX-hROR1 (cells referred as to “ROR1”) or the pCMX-mROR4 (cells referred as to “ROR4”) expression vector, or with the pCMX insertless vector (“control” cells). A, Total RNA obtained from HepG2 (left panel) and Hep3B (right panel) stably transfected cells was analyzed for Rora and Fib- mRNAs by Q-RT-PCR. SerpinA1 and GAPDH mRNAs were monitored as controls. Results are expressed relative to the means of the “control” cells for each of the three (for HepG2 cells) or two (for Hep3B cells) pools of clones of the control, ROR1, and ROR4 groups. B, Rora1 and Rora4 mRNAs were analyzed by semiquantitative RT-PCR (25 amplification cycles). Aliquots of the PCR mixture were submitted to electrophoresis and transferred to nitrocellulose filters, which were then hybridized with [-32P]-labeled probes specific for Rora. Autoradiograms are shown. C, Nuclear proteins prepared from stably transfected HepG2 cells were analyzed by Western blotting with an antiserum against ROR (lanes 3–5). A mix of lysates programmed for producing ROR1 and ROR4 proteins (lane 1) and the control unprogrammed lysate (lane 2) were processed simultaneously. The Ponceau Red staining of the proteins present in lanes 1–5 is shown as a control for protein loading and transfer (lanes 1*–5*). unprog., Unprogrammed; Q-PCR, quantitative PCR; SerpA1, serpinA1.

Journal: Molecular endocrinology (Baltimore, Md.)

Article Title: The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.

doi: 10.1210/me.2005-0153

Figure Lengend Snippet: Fig. 3. Stably Transfected HepG2 and Hep3B Hepatoma Cells Overexpressing ROR Have Higher Fibrinogen- mRNA Levels HepG2 and Hep3B human hepatoma cells were stably transfected with the pCMX-hROR1 (cells referred as to “ROR1”) or the pCMX-mROR4 (cells referred as to “ROR4”) expression vector, or with the pCMX insertless vector (“control” cells). A, Total RNA obtained from HepG2 (left panel) and Hep3B (right panel) stably transfected cells was analyzed for Rora and Fib- mRNAs by Q-RT-PCR. SerpinA1 and GAPDH mRNAs were monitored as controls. Results are expressed relative to the means of the “control” cells for each of the three (for HepG2 cells) or two (for Hep3B cells) pools of clones of the control, ROR1, and ROR4 groups. B, Rora1 and Rora4 mRNAs were analyzed by semiquantitative RT-PCR (25 amplification cycles). Aliquots of the PCR mixture were submitted to electrophoresis and transferred to nitrocellulose filters, which were then hybridized with [-32P]-labeled probes specific for Rora. Autoradiograms are shown. C, Nuclear proteins prepared from stably transfected HepG2 cells were analyzed by Western blotting with an antiserum against ROR (lanes 3–5). A mix of lysates programmed for producing ROR1 and ROR4 proteins (lane 1) and the control unprogrammed lysate (lane 2) were processed simultaneously. The Ponceau Red staining of the proteins present in lanes 1–5 is shown as a control for protein loading and transfer (lanes 1*–5*). unprog., Unprogrammed; Q-PCR, quantitative PCR; SerpA1, serpinA1.

Article Snippet: HepG2 and Hep3B human hepatoma cells (American Type Culture Collection, Manassas, VA; HB-8065 and HB-8064, respectively) were cultured in a 1:1 mixture of DMEM and Ham-F12 media with Glutamax-I, supplemented with 10% (vol/vol) fetal bovine serum, 100 g/ml gentamycin, and 2.5 g/ml fungizone (all from Invitrogen, San Diego, CA) as previously described (24).

Techniques: Stable Transfection, Transfection, Expressing, Plasmid Preparation, Control, Reverse Transcription Polymerase Chain Reaction, Clone Assay, Amplification, Electrophoresis, Labeling, Western Blot, Staining, Real-time Polymerase Chain Reaction

Fig. 4. hROR Is Recruited to the Fibrinogen- Promoter in HepG2 Human Hepatoma Cells Soluble chromatin was prepared from the pCMX-hROR1, and from the pCMX, stably transfected HepG2 cells and immunoprecipitated (IP) with an anti-ROR antiserum or with an antihemagglutinin (HA) antiserum as a negative control. The final DNA extractions were PCR amplified using pairs of primers covering either the fibrinogen- promoter (468 to 103) with the (366/355) fibrinogen--RORE (top panel) or a fragment of the -actin gene as a negative control (bottom panel), and the PCR products were analyzed by electro- phoresis. Aliquots of DNA taken before the precipitation step (input) were also submitted to PCR as controls. -Act, - Actin.

Journal: Molecular endocrinology (Baltimore, Md.)

Article Title: The gene encoding fibrinogen-beta is a target for retinoic acid receptor-related orphan receptor alpha.

doi: 10.1210/me.2005-0153

Figure Lengend Snippet: Fig. 4. hROR Is Recruited to the Fibrinogen- Promoter in HepG2 Human Hepatoma Cells Soluble chromatin was prepared from the pCMX-hROR1, and from the pCMX, stably transfected HepG2 cells and immunoprecipitated (IP) with an anti-ROR antiserum or with an antihemagglutinin (HA) antiserum as a negative control. The final DNA extractions were PCR amplified using pairs of primers covering either the fibrinogen- promoter (468 to 103) with the (366/355) fibrinogen--RORE (top panel) or a fragment of the -actin gene as a negative control (bottom panel), and the PCR products were analyzed by electro- phoresis. Aliquots of DNA taken before the precipitation step (input) were also submitted to PCR as controls. -Act, - Actin.

Article Snippet: HepG2 and Hep3B human hepatoma cells (American Type Culture Collection, Manassas, VA; HB-8065 and HB-8064, respectively) were cultured in a 1:1 mixture of DMEM and Ham-F12 media with Glutamax-I, supplemented with 10% (vol/vol) fetal bovine serum, 100 g/ml gentamycin, and 2.5 g/ml fungizone (all from Invitrogen, San Diego, CA) as previously described (24).

Techniques: Stable Transfection, Transfection, Immunoprecipitation, Negative Control, Amplification

( A ) Transcriptional levels of the avpr1b in hypothalamus, pancreas, jejunum, kidney, liver, and spleen of WT mice on water Ctrl (clear purple bars) or receiving a 10% Frct solution for 30 weeks (solid purple bars). ( B ) Transcriptional levels of the avpr1a (red line) and the avpr1b (purple line) in liver of WT mice receiving a 10% Frct solution for 30 weeks. ( C and D ) Representative Western blot and densitometry ( n = 2 total blots) for the V1bR, fructokinase (KHK), and actin in human HepG2 cells Ctrl or exposed to AVP (250 nM), Frct (10 mM), or a combination of Frct plus AVP for 5 days. ( E ) KHK activity in HepG2 lysates from Ctrl, AVP, Frct, and Frct plus AVP cells. ( F ) Representative Western blot and densitometry ( n = 2 total blots) for V1bR and actin in HepG2 transduced with noncodifying shRNA ( scr ) or shRNA against avpr1b ( shAvpr1b ) at baseline or a Frct (10 mM) exposure. ( G ) Representative Western blot and densitometry ( n = 2 total blots) for KHK and actin in Ctrl, AVP, Frct, and Frct plus AVP HepG2 cells stably silenced for V1bR expression. ( H and I ) Representative Western blot ( n = 2 total blots) and densitometry for KHK, actin, and lipogenic enzymes FAS and ACC in the liver of WT and V1bR-KO mice on water Ctrl or receiving a 10% Frct solution for 30 weeks. The data in A and C–E are presented as the mean ± SD and analyzed by 1-way ANOVA with Tukey’s post hoc analysis. * P < 0.05, ** P < 0.01. For A and B and E , n = 6 mice per group. For C – E , n = 2 independent cultured plates. V1bR, vasopressin 1b receptor; avpr1b , vasopressin 1b receptor gene; avpr1a , vasopressin 1a receptor gene; KHK, ketohexokinase; Ctrl, control; AVP, vasopressin; Frct, fructose; scr , scramble; FAS, fatty acid synthase; ACC, acetyl-CoA carboxylase.

Journal: JCI Insight

Article Title: Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor

doi: 10.1172/jci.insight.140848

Figure Lengend Snippet: ( A ) Transcriptional levels of the avpr1b in hypothalamus, pancreas, jejunum, kidney, liver, and spleen of WT mice on water Ctrl (clear purple bars) or receiving a 10% Frct solution for 30 weeks (solid purple bars). ( B ) Transcriptional levels of the avpr1a (red line) and the avpr1b (purple line) in liver of WT mice receiving a 10% Frct solution for 30 weeks. ( C and D ) Representative Western blot and densitometry ( n = 2 total blots) for the V1bR, fructokinase (KHK), and actin in human HepG2 cells Ctrl or exposed to AVP (250 nM), Frct (10 mM), or a combination of Frct plus AVP for 5 days. ( E ) KHK activity in HepG2 lysates from Ctrl, AVP, Frct, and Frct plus AVP cells. ( F ) Representative Western blot and densitometry ( n = 2 total blots) for V1bR and actin in HepG2 transduced with noncodifying shRNA ( scr ) or shRNA against avpr1b ( shAvpr1b ) at baseline or a Frct (10 mM) exposure. ( G ) Representative Western blot and densitometry ( n = 2 total blots) for KHK and actin in Ctrl, AVP, Frct, and Frct plus AVP HepG2 cells stably silenced for V1bR expression. ( H and I ) Representative Western blot ( n = 2 total blots) and densitometry for KHK, actin, and lipogenic enzymes FAS and ACC in the liver of WT and V1bR-KO mice on water Ctrl or receiving a 10% Frct solution for 30 weeks. The data in A and C–E are presented as the mean ± SD and analyzed by 1-way ANOVA with Tukey’s post hoc analysis. * P < 0.05, ** P < 0.01. For A and B and E , n = 6 mice per group. For C – E , n = 2 independent cultured plates. V1bR, vasopressin 1b receptor; avpr1b , vasopressin 1b receptor gene; avpr1a , vasopressin 1a receptor gene; KHK, ketohexokinase; Ctrl, control; AVP, vasopressin; Frct, fructose; scr , scramble; FAS, fatty acid synthase; ACC, acetyl-CoA carboxylase.

Article Snippet: V1b deletion in HepG2 cells was performed employing lentiviral particles containing either shRNA sequences specific for human V1bR (Santa Cruz Biotechnologies, sc-40277-v) or scramble — noncodifying — shRNA control (sc-108080).

Techniques: Western Blot, Activity Assay, Transduction, shRNA, Stable Transfection, Expressing, Cell Culture, Control

FIG. 6. Liver histology of a HepG2-hIL-6R tumor that developed 1 month following intrasplenic injection into a SCID . BNX chimeric mice (H & E staining).

Journal: Virology

Article Title: Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.

doi: 10.1006/viro.2000.0210

Figure Lengend Snippet: FIG. 6. Liver histology of a HepG2-hIL-6R tumor that developed 1 month following intrasplenic injection into a SCID . BNX chimeric mice (H & E staining).

Article Snippet: To further assess the role of hIL-6 in supporting HBV infection, a human hepatoblastoma cell line HepG2 (ATCC HB 8065), a HepG2derived, stably transfected hIL-6Ra (gp80) cell line (HepG2-hIL-6Ra) and a null hIL-6R (a cell line which does not express hIL-6Ra) named HepG2-PDI (RoseJohn et al., 1993), were incubated with HBV DNA-positive sera, with or without hIL-6.

Techniques: Injection, Staining

Diethyl maleate stimulates Nrf2 but not FOXO-dependent gene expression. HepG2 cells were exposed to DEM (1 mM) for 4 h or 16 h in serum-free DMEM (A) , followed by analysis of G6PC and SELENOP mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. (B) HepG2 cells, grown to approx. 75% confluence, were held on serum-free medium for 18 h, followed by exposure to DEM at the given concentrations for 2 h. If indicated, this was followed by a 30 min incubation with insulin (100 nM). Nuclear extracts were prepared and binding of endogenous FOXO1 to an oligonucleotide containing FOXO binding elements analyzed in an ELISA-based approach. Data are means of three independent experiments + SD. (C) HepG2 cells were exposed to DEM for 4 h or 16 h, followed by analysis of Nrf2 target gene mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. Statistical significance was assessed using Student's t -test: *P < 0.05, **P < 0.01 vs. respective control.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Diethyl maleate stimulates Nrf2 but not FOXO-dependent gene expression. HepG2 cells were exposed to DEM (1 mM) for 4 h or 16 h in serum-free DMEM (A) , followed by analysis of G6PC and SELENOP mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. (B) HepG2 cells, grown to approx. 75% confluence, were held on serum-free medium for 18 h, followed by exposure to DEM at the given concentrations for 2 h. If indicated, this was followed by a 30 min incubation with insulin (100 nM). Nuclear extracts were prepared and binding of endogenous FOXO1 to an oligonucleotide containing FOXO binding elements analyzed in an ELISA-based approach. Data are means of three independent experiments + SD. (C) HepG2 cells were exposed to DEM for 4 h or 16 h, followed by analysis of Nrf2 target gene mRNA levels by qRT-PCR. Data are means of five independent experiments + SD. Statistical significance was assessed using Student's t -test: *P < 0.05, **P < 0.01 vs. respective control.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Gene Expression, Quantitative RT-PCR, Incubation, Binding Assay, Enzyme-linked Immunosorbent Assay, Control

Role of FOXO1 cysteine residues and of FOXO phosphorylation in DEM response. (A) HEK293 or HepG2 cells transiently expressing GFP-coupled human mutant FOXO1 [FOXO1(C#1-7S)] were exposed to the given concentrations of DEM followed by analysis of subcellular distribution of GFP-FOXO1 as described in the legend to A. (B) HepG2 cells were transfected with a plasmid encoding a GFP-coupled form of FOXO1(WT) or the cysteine-deficient mutant FOXO1(C#1-7S). Cells were exposed to DEM (3 mM) or DMSO (solvent control) for 2 h, followed by 30 min exposure to insulin (100 nM) as indicated. FOXO1 and phospho-FOXO1 were detected by Western blotting, actin detection was used as gel loading control. Blots are representative of three independent experiments. (C) DEM stimulates JNK. HepG2 cells were incubated in the presence of 10 µM SP600125 (or DMSO as solvent control) for 1 h, followed by exposure to DEM at the given concentration for 1 h in the continued presence of SP600125 (or solvent control). Cells were lysed and subjected to SDS-PAGE and Western analysis of JNK and cJun phosphorylation. The blots shown are representative of two independent experiments. (D) DEM-induced nuclear accumulation of FOXO1 is independent of JNK. HepG2 cells were transfected with a plasmid expressing GFP-FOXO1 24 h prior to exposure to SP600125 (10 µM) and DEM (3 mM) as in (C). Analysis of subcellular localization of GFP-FOXO1 was done by categorizing cells according to the predominant FOXO1 distribution into “cytoplasm”, “cytoplasm/nucleus”, and “nucleus”. Subcellular distribution of GFP-FOXO1 in cells was calculated from three independent experiments. In each of these experiments, at least 198 cells were categorized per setting. Data are given as means + SD.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Role of FOXO1 cysteine residues and of FOXO phosphorylation in DEM response. (A) HEK293 or HepG2 cells transiently expressing GFP-coupled human mutant FOXO1 [FOXO1(C#1-7S)] were exposed to the given concentrations of DEM followed by analysis of subcellular distribution of GFP-FOXO1 as described in the legend to A. (B) HepG2 cells were transfected with a plasmid encoding a GFP-coupled form of FOXO1(WT) or the cysteine-deficient mutant FOXO1(C#1-7S). Cells were exposed to DEM (3 mM) or DMSO (solvent control) for 2 h, followed by 30 min exposure to insulin (100 nM) as indicated. FOXO1 and phospho-FOXO1 were detected by Western blotting, actin detection was used as gel loading control. Blots are representative of three independent experiments. (C) DEM stimulates JNK. HepG2 cells were incubated in the presence of 10 µM SP600125 (or DMSO as solvent control) for 1 h, followed by exposure to DEM at the given concentration for 1 h in the continued presence of SP600125 (or solvent control). Cells were lysed and subjected to SDS-PAGE and Western analysis of JNK and cJun phosphorylation. The blots shown are representative of two independent experiments. (D) DEM-induced nuclear accumulation of FOXO1 is independent of JNK. HepG2 cells were transfected with a plasmid expressing GFP-FOXO1 24 h prior to exposure to SP600125 (10 µM) and DEM (3 mM) as in (C). Analysis of subcellular localization of GFP-FOXO1 was done by categorizing cells according to the predominant FOXO1 distribution into “cytoplasm”, “cytoplasm/nucleus”, and “nucleus”. Subcellular distribution of GFP-FOXO1 in cells was calculated from three independent experiments. In each of these experiments, at least 198 cells were categorized per setting. Data are given as means + SD.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Phospho-proteomics, Expressing, Mutagenesis, Transfection, Plasmid Preparation, Solvent, Control, Western Blot, Incubation, Concentration Assay, SDS Page

Analysis of subcellular localization of FOXO1 upon exposure to Leptomycin B or DEM. HepG2 cells were transfected with an expression plasmid coding for GFP-FOXO1, followed by exposure to the given compounds and analysis of subcellular distribution of GFP-FOXO1 as described before. (A) Cells were exposed to Leptomycin B (LMB) at 30 ng/mL for 30 min, followed by addition of insulin (100 nM) for another 30 min. In the panel on the right, insulin was added first (30 min), followed by LMB (30 min) prior to analysis of GFP-FOXO1 subcellular localization. (B) Cells were treated as in (A), with DEM (10 mM) instead of LMB. Subcellular distribution of EGFP-FOXO1 in cells was calculated from three independent experiments. On average, 210 (min: 124, max: 267) cells were categorized per condition in each of the independent experiments. Data are given as means + SD. (C) HepG2 cells expressing EGFP-FOXO1 were exposed to insulin (causing nuclear exclusion) and DEM (3 mM) or solvent control (DMSO) for the indicated times. Analysis of subcellular distribution of EGFP-FOXO1 was done as described in Materials and Methods.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Analysis of subcellular localization of FOXO1 upon exposure to Leptomycin B or DEM. HepG2 cells were transfected with an expression plasmid coding for GFP-FOXO1, followed by exposure to the given compounds and analysis of subcellular distribution of GFP-FOXO1 as described before. (A) Cells were exposed to Leptomycin B (LMB) at 30 ng/mL for 30 min, followed by addition of insulin (100 nM) for another 30 min. In the panel on the right, insulin was added first (30 min), followed by LMB (30 min) prior to analysis of GFP-FOXO1 subcellular localization. (B) Cells were treated as in (A), with DEM (10 mM) instead of LMB. Subcellular distribution of EGFP-FOXO1 in cells was calculated from three independent experiments. On average, 210 (min: 124, max: 267) cells were categorized per condition in each of the independent experiments. Data are given as means + SD. (C) HepG2 cells expressing EGFP-FOXO1 were exposed to insulin (causing nuclear exclusion) and DEM (3 mM) or solvent control (DMSO) for the indicated times. Analysis of subcellular distribution of EGFP-FOXO1 was done as described in Materials and Methods.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Transfection, Expressing, Plasmid Preparation, Solvent, Control

Analysis of subcellular localization of FOXO1 upon exposure to stressful stimuli. HepG2 cells were transfected with an expression plasmid coding for GFP-FOXO1, followed by exposure to the given compounds and analysis of subcellular distribution of GFP-FOXO1 as described before. (A) Cells were treated with DEM (2 mM) for 30 min, followed by addition of insulin (left), sodium arsenite (100 µM, middle) or copper sulfate (10 µM, right) for another 60 min. Data are means of at least three independent experiments + SD. On average, 149 (min: 92, max: 240) cells were categorized per condition in each of the independent experiments. (B) Schematic summary of findings: DEM causes nuclear accumulation of FOXO1 by blocking its nuclear exclusion. Nuclear exclusion elicited by stimuli such as insulin, copper ions or arsenite is attenuated by DEM. Abbreviations in scheme: InsR, insulin receptor; IGF1-R, insulin-like growth factor.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Analysis of subcellular localization of FOXO1 upon exposure to stressful stimuli. HepG2 cells were transfected with an expression plasmid coding for GFP-FOXO1, followed by exposure to the given compounds and analysis of subcellular distribution of GFP-FOXO1 as described before. (A) Cells were treated with DEM (2 mM) for 30 min, followed by addition of insulin (left), sodium arsenite (100 µM, middle) or copper sulfate (10 µM, right) for another 60 min. Data are means of at least three independent experiments + SD. On average, 149 (min: 92, max: 240) cells were categorized per condition in each of the independent experiments. (B) Schematic summary of findings: DEM causes nuclear accumulation of FOXO1 by blocking its nuclear exclusion. Nuclear exclusion elicited by stimuli such as insulin, copper ions or arsenite is attenuated by DEM. Abbreviations in scheme: InsR, insulin receptor; IGF1-R, insulin-like growth factor.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Transfection, Expressing, Plasmid Preparation, Blocking Assay

Glutathione depletion and oxidation in HepG2 cells exposed to diethyl maleate. Analysis of glutathione (GSH, A) and glutathione disulfide (GSSG, B) content of hepatoma cell lysates following exposure to the given concentrations of DEM or solvent (DMSO, “0 mM DEM”) for 120 min. Data are means of four independent experiments + SD.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Glutathione depletion and oxidation in HepG2 cells exposed to diethyl maleate. Analysis of glutathione (GSH, A) and glutathione disulfide (GSSG, B) content of hepatoma cell lysates following exposure to the given concentrations of DEM or solvent (DMSO, “0 mM DEM”) for 120 min. Data are means of four independent experiments + SD.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Solvent

Diethyl maleate causes nuclear accumulation of FOXO1. (A, B) HEK293 or HepG2 cells transiently expressing GFP-coupled human FOXO1 (wildtype) were exposed to the given concentrations of DEM (“0”: solvent control, DMSO) for 30 min, followed by analysis of subcellular distribution of GFP-FOXO1. At least 200 cells were categorized for each independent experiment with respect to the predominant subcellular localization of GFP-FOXO1. Data are presented as means of three independent experiments + SD. (C) Images of HepG2 cells expressing GFP-FOXO1 prior to (Ctrl.) and after addition of insulin (Ins, 100 nM) and DEM (3 mM) as described in . The images shown provide examples of cells with GFP-FOXO1 in both nuclear and cytoplasmic compartments (Ctrl), predominantly cytoplasmic (insulin) and predominantly nuclear (DEM) localization. (D) Age-synchronized L1 larvae of the C. elegans TJ356 strain stably expressing a DAF-16::GFP fusion protein were transferred to NGM agar plates supplemented with DEM at 1 mM. 0.1% DMSO was used as control (Ctrl); exposure was for 24 h. Examples of worms with predominantly cytoplasmic (left) and nuclear localization (right, see arrows, inset) of DAF-16::GFP are shown. The experiment was performed at least three independent times. Bar = 100 µm.

Journal: Redox Biology

Article Title: Nuclear trapping of inactive FOXO1 by the Nrf2 activator diethyl maleate

doi: 10.1016/j.redox.2018.09.010

Figure Lengend Snippet: Diethyl maleate causes nuclear accumulation of FOXO1. (A, B) HEK293 or HepG2 cells transiently expressing GFP-coupled human FOXO1 (wildtype) were exposed to the given concentrations of DEM (“0”: solvent control, DMSO) for 30 min, followed by analysis of subcellular distribution of GFP-FOXO1. At least 200 cells were categorized for each independent experiment with respect to the predominant subcellular localization of GFP-FOXO1. Data are presented as means of three independent experiments + SD. (C) Images of HepG2 cells expressing GFP-FOXO1 prior to (Ctrl.) and after addition of insulin (Ins, 100 nM) and DEM (3 mM) as described in . The images shown provide examples of cells with GFP-FOXO1 in both nuclear and cytoplasmic compartments (Ctrl), predominantly cytoplasmic (insulin) and predominantly nuclear (DEM) localization. (D) Age-synchronized L1 larvae of the C. elegans TJ356 strain stably expressing a DAF-16::GFP fusion protein were transferred to NGM agar plates supplemented with DEM at 1 mM. 0.1% DMSO was used as control (Ctrl); exposure was for 24 h. Examples of worms with predominantly cytoplasmic (left) and nuclear localization (right, see arrows, inset) of DAF-16::GFP are shown. The experiment was performed at least three independent times. Bar = 100 µm.

Article Snippet: HepG2 human hepatoma cells and HEK293 human embryonic kidney cells were obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany).

Techniques: Expressing, Solvent, Control, Stable Transfection

(A) Quantification of BDP metabolites produced by A549 cells treated with BDP or BDP with esterase inhibitors (+EI). (B) Relative quantification of BDP metabolites produced by DPX2 cells treated with BDP or BDP with esterase inhibitors (+EI). Data are the mean and standard deviation from six replicates. n.d. Signifies that the metabolite was not detected. (C and D) CYP3A enzyme mRNA abundance, measured by qPCR in A549 (C) and DPX2 (D) cells. Data are represented as the number of mRNA copies per 10,000 copies of β2-macroglobulin (a “housekeeping” gene). Statistics used for A549 cell data analysis were one-way analysis of variance with Dunnett’s post-hoc test. For DPX2 cell data analysis two-way ANOVA with Bonferronni post-hoc testing was used. Data are the mean and standard deviation from 6 replicates. n.d. Signifies that mRNA was not detected. *P < 0.05; ***P < 0.001; ****P < 0.0001.

Journal: The Journal of Pharmacology and Experimental Therapeutics

Article Title: Metabolism of Beclomethasone Dipropionate by Cytochrome P450 3A Enzymes

doi: 10.1124/jpet.112.202556

Figure Lengend Snippet: (A) Quantification of BDP metabolites produced by A549 cells treated with BDP or BDP with esterase inhibitors (+EI). (B) Relative quantification of BDP metabolites produced by DPX2 cells treated with BDP or BDP with esterase inhibitors (+EI). Data are the mean and standard deviation from six replicates. n.d. Signifies that the metabolite was not detected. (C and D) CYP3A enzyme mRNA abundance, measured by qPCR in A549 (C) and DPX2 (D) cells. Data are represented as the number of mRNA copies per 10,000 copies of β2-macroglobulin (a “housekeeping” gene). Statistics used for A549 cell data analysis were one-way analysis of variance with Dunnett’s post-hoc test. For DPX2 cell data analysis two-way ANOVA with Bonferronni post-hoc testing was used. Data are the mean and standard deviation from 6 replicates. n.d. Signifies that mRNA was not detected. *P < 0.05; ***P < 0.001; ****P < 0.0001.

Article Snippet: DPX2 cells (HepG2 background with human PXR stably overexpressed to drive the expression of a CYP3A4 reporter gene construct by PXR agonists) were provided by Dr. Judy Raucy (Puracyp Inc., Carlsbad, CA).

Techniques: Produced, Quantitative Proteomics, Standard Deviation

(A) Expression of GREB1, TFF1, and WISP-2 by qPCR analysis in HepG2 cells stably expressing WT or ERα-Q375H treated with vehicle or the indicated concentrations of E2. The samples (n = 4) were normalized to human ACTB expression. The fold changes by log2 transform were calculated relative to the HepG2/WT ERα vehicle ± SEM, using the two-way ANOVA with Tukey’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, or ****P < 0.0001). (B) Comparisons of protein interactomes of WT ERα and ERα-Q375H (QH) ERα. Venn diagrams show unliganded interactions and liganded interactions. The interactions unique to WT and ERα-Q375H are listed. (C) Interactions of ERα, GREB1, HDAC1, and GADD45G with WT ERα or Q375H mutant ERα by RIME analysis of chromatin extracts from HepG2 cells stably expressing WT or ERα-Q375H and treated with vehicle or 10 nM E2. RIME assay was carried out using an ERα antibody to identify the proteins that interacted with ERα using mass spectrometry.

Journal: Science signaling

Article Title: A mutant form of ERα associated with estrogen insensitivity affects the coupling between ligand binding and coactivator recruitment

doi: 10.1126/scisignal.aaw4653

Figure Lengend Snippet: (A) Expression of GREB1, TFF1, and WISP-2 by qPCR analysis in HepG2 cells stably expressing WT or ERα-Q375H treated with vehicle or the indicated concentrations of E2. The samples (n = 4) were normalized to human ACTB expression. The fold changes by log2 transform were calculated relative to the HepG2/WT ERα vehicle ± SEM, using the two-way ANOVA with Tukey’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001, or ****P < 0.0001). (B) Comparisons of protein interactomes of WT ERα and ERα-Q375H (QH) ERα. Venn diagrams show unliganded interactions and liganded interactions. The interactions unique to WT and ERα-Q375H are listed. (C) Interactions of ERα, GREB1, HDAC1, and GADD45G with WT ERα or Q375H mutant ERα by RIME analysis of chromatin extracts from HepG2 cells stably expressing WT or ERα-Q375H and treated with vehicle or 10 nM E2. RIME assay was carried out using an ERα antibody to identify the proteins that interacted with ERα using mass spectrometry.

Article Snippet: HepG2 cells were maintained in phenol red–free minimum essential medium (MEM) (Invitrogen), and HEK293 cells were maintained in phenol red–free Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (FBS; Gemini Bio-Products) and 4 mM l-glutamine (Invitrogen).

Techniques: Expressing, Stable Transfection, Comparison, Mutagenesis, Mass Spectrometry

Excess glucose availability promotes GLUT1 clearance from the plasma membrane (A) HeLa cells were cultured for 24 h in media with no glucose, then switched to high glucose media (25 mM) for the indicated amount of time. Biotin-labeling was performed at the post-glucose shift time points. Following biotinylation, labeled cells were lysed and surface proteins were affinity purified with NeutrAvidin beads (Thermo Scientific). Analysis was performed by SDS-PAGE and immunoblot with antibodies that recognize GLUT1, Na + /K + ATPase, and GAPDH. (B,C) Quantification of captured GLUT1 (B) and Na + /K + ATPase (C) for the experiment shown in (A) was performed over multiple biological replicates (n ≥ 3). GLUT1 measurements were taken of the whole lane using FIJI. Immunoblots for biological replicate experiments are provided in . (D) HeLa cells stably expressing mCherry-CaaX (red) were cultured in no glucose media for 24 h (top row) then shifted to high glucose (25 mM) for 24 h (bottom row), at which point the samples were fixed for immunofluorescence detection with GLUT1 antibody (green). Zoomed images provided in the far right column correspond to the yellow dashed-line inset boxes in the

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: Excess glucose availability promotes GLUT1 clearance from the plasma membrane (A) HeLa cells were cultured for 24 h in media with no glucose, then switched to high glucose media (25 mM) for the indicated amount of time. Biotin-labeling was performed at the post-glucose shift time points. Following biotinylation, labeled cells were lysed and surface proteins were affinity purified with NeutrAvidin beads (Thermo Scientific). Analysis was performed by SDS-PAGE and immunoblot with antibodies that recognize GLUT1, Na + /K + ATPase, and GAPDH. (B,C) Quantification of captured GLUT1 (B) and Na + /K + ATPase (C) for the experiment shown in (A) was performed over multiple biological replicates (n ≥ 3). GLUT1 measurements were taken of the whole lane using FIJI. Immunoblots for biological replicate experiments are provided in . (D) HeLa cells stably expressing mCherry-CaaX (red) were cultured in no glucose media for 24 h (top row) then shifted to high glucose (25 mM) for 24 h (bottom row), at which point the samples were fixed for immunofluorescence detection with GLUT1 antibody (green). Zoomed images provided in the far right column correspond to the yellow dashed-line inset boxes in the "MERGE" image to the left. (E) Quantification of co-localization shown in (D) was measured by Pearson correlation on Softworx software (n = 30 cells), p = 3.75 × 10 -8 . (F) HeLa cells stably expressing GLUT1-GFP (green) were cultured using the conditions indicated in (D). Prior to imaging, cells were pulse-labeled with FM4-64 (red), a lipophilic tracer dye that inserts into the outer leaflet of the cell membrane. Live cells were incubated on ice in 8 μM cold FM4-64 for ∼5 min before imaging. Zoomed images provided in the far right column correspond to the yellow dashed-line inset boxes in the "MERGE" image to the left. (G) Quantification of the results shown in (F). Pearson correlation coefficient was measured using Softworx software (n = 30 cells), p = 1.69 × 10 -24 . For all experiments, p values were computed using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Clinical Proteomics, Membrane, Cell Culture, Labeling, Affinity Purification, SDS Page, Western Blot, Stable Transfection, Expressing, Immunofluorescence, Software, Imaging, Incubation

Glucose-stimulated clearance of GLUT1 results in trafficking to lysosomes (A) Imaging of endogenous GLUT1 was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with GLUT1 antibody (green) and LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization (as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 1 × 10 -5 . (B) Imaging of stably expressed GLUT1-GFP (green) was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 1 × 10 -6 . (C) Imaging of stably expressed GLUT1-FLAG, which harbors a FLAG tag on its first exofacial loop, was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with FLAG antibody (green) and LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 0.004. For all experiments, p values were computed using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: Glucose-stimulated clearance of GLUT1 results in trafficking to lysosomes (A) Imaging of endogenous GLUT1 was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with GLUT1 antibody (green) and LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization (as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 1 × 10 -5 . (B) Imaging of stably expressed GLUT1-GFP (green) was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 1 × 10 -6 . (C) Imaging of stably expressed GLUT1-FLAG, which harbors a FLAG tag on its first exofacial loop, was performed in HeLa cells cultured in no glucose media for 24 h then switched to high glucose media (25 mM) for the indicated time and fixed. Samples were imaged via immunofluorescence and probed with FLAG antibody (green) and LAMP1 antibody (red). A schematic of the detection strategy is shown in the top left of the panel. Quantification of co-localization as measured by Pearson correlation on Softworx software (n = 30 cells) is shown in the graph at the top right of the panel. ∗∗ indicates p < 0.004. For all experiments, p values were computed using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Imaging, Cell Culture, Immunofluorescence, Software, Stable Transfection, FLAG-tag

Characterization of the GLUT1 trafficking itinerary stimulated by excess glucose availability HeLa cells expressing the three versions of GLUT1 described in <xref ref-type=Figure 2 were cultured in media lacking glucose for 24 h then either fixed or switched to high glucose media and fixed at the indicated time points. Cells were then probed by immunofluorescence for the endosomal proteins VPS35 (A-B) or CD63 (C-D) (red). In each case, co-localization was analyzed for endogenous GLUT1 (left, green), GLUT1-GFP (middle, green), or GLUT1-FLAG (right, green). Co-localization of GLUT1 signal with VPS35 (B) and CD63 (D) was quantified over the glucose stimulation time course. Co-localization measurements were made in Softworx using Pearson correlation coefficient (n = 30 cells). ∗∗ indicates p < 0.002. (E) Summarized profile of the GLUT1 trafficking itinerary stimulated by excess glucose availability. Heat maps showing co-localization of endogenous GLUT1 (top), GLUT1-GFP (middle), and exofacial GLUT1-FLAG (bottom) with different markers along the endocytic/endosomal trafficking route. For each time point and each marker, at least 21 measurements were made of the Pearson coefficient of correlation using Softworx software. The color in each box is weighted based on the average Pearson coefficient (n ≥ 21) at the indicated time point. (F) HeLa cells harboring a doxycycline-inducible dominant-negative VPS4 variant (VPS4 E228Q -HA) were cultured in no glucose media + 1 μg/ml doxycycline for 24 h then fixed or switched to high glucose media + doxycycline and fixed at the indicated time point. Cells were then imaged for immunofluorescence detection of HA (red) and GLUT1 (green). VPS4 E228Q is a dominant-negative mutant that accumulates on late-endosomal compartments responsible for sorting cargo into intraluminal vesicles. GLUT1 puncta that co-localize with, and are surrounded by, VPS4 E228Q -HA are marked with white arrows. (G) Quantification of the experiments represented in (F) by measuring the Pearson coefficient of correlation (n = 30 cells) using Softworx software. ∗∗ indicates p < 0.001. (H) HeLa cells stably expressing both GLUT1-GFP (green) and doxycycline-inducible VPS4 E228Q -HA were cultured as described in (F) and then imaged for immunofluorescence detection of HA (red). GLUT1-GFP puncta that co-localize with, and are surrounded by, VPS4 E228Q -HA are marked with white arrows. (I) Quantification of the experiments represented in (H) by measuring the Pearson coefficient of correlation (n = 30 cells) using Softworx software. ∗∗ indicates p < 0.02. For all experiments, p values were computed using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. " width="100%" height="100%">

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: Characterization of the GLUT1 trafficking itinerary stimulated by excess glucose availability HeLa cells expressing the three versions of GLUT1 described in Figure 2 were cultured in media lacking glucose for 24 h then either fixed or switched to high glucose media and fixed at the indicated time points. Cells were then probed by immunofluorescence for the endosomal proteins VPS35 (A-B) or CD63 (C-D) (red). In each case, co-localization was analyzed for endogenous GLUT1 (left, green), GLUT1-GFP (middle, green), or GLUT1-FLAG (right, green). Co-localization of GLUT1 signal with VPS35 (B) and CD63 (D) was quantified over the glucose stimulation time course. Co-localization measurements were made in Softworx using Pearson correlation coefficient (n = 30 cells). ∗∗ indicates p < 0.002. (E) Summarized profile of the GLUT1 trafficking itinerary stimulated by excess glucose availability. Heat maps showing co-localization of endogenous GLUT1 (top), GLUT1-GFP (middle), and exofacial GLUT1-FLAG (bottom) with different markers along the endocytic/endosomal trafficking route. For each time point and each marker, at least 21 measurements were made of the Pearson coefficient of correlation using Softworx software. The color in each box is weighted based on the average Pearson coefficient (n ≥ 21) at the indicated time point. (F) HeLa cells harboring a doxycycline-inducible dominant-negative VPS4 variant (VPS4 E228Q -HA) were cultured in no glucose media + 1 μg/ml doxycycline for 24 h then fixed or switched to high glucose media + doxycycline and fixed at the indicated time point. Cells were then imaged for immunofluorescence detection of HA (red) and GLUT1 (green). VPS4 E228Q is a dominant-negative mutant that accumulates on late-endosomal compartments responsible for sorting cargo into intraluminal vesicles. GLUT1 puncta that co-localize with, and are surrounded by, VPS4 E228Q -HA are marked with white arrows. (G) Quantification of the experiments represented in (F) by measuring the Pearson coefficient of correlation (n = 30 cells) using Softworx software. ∗∗ indicates p < 0.001. (H) HeLa cells stably expressing both GLUT1-GFP (green) and doxycycline-inducible VPS4 E228Q -HA were cultured as described in (F) and then imaged for immunofluorescence detection of HA (red). GLUT1-GFP puncta that co-localize with, and are surrounded by, VPS4 E228Q -HA are marked with white arrows. (I) Quantification of the experiments represented in (H) by measuring the Pearson coefficient of correlation (n = 30 cells) using Softworx software. ∗∗ indicates p < 0.02. For all experiments, p values were computed using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Expressing, Cell Culture, Immunofluorescence, Marker, Software, Dominant Negative Mutation, Variant Assay, Stable Transfection

The clathrin-binding motif and PY motifs of TXNIP are required for glucose-mediated GLUT1 trafficking to lysosomes (A) HeLa cells stably expressing a doxycycline-inducible expression vector were cultured using the conditions described in <xref ref-type=Figure 1 D and, for the induced samples, additionally treated with 1 μg/ml doxycycline for the last 24 h before fixation. Cells were fixed and imaged for immunofluorescence detection of GLUT1 (green) and LAMP1 (red), a marker of lysosomal compartments. Zoomed images provided in the bottom row correspond to the blue dashed-line inset boxes of the top row. (B) Quantification of the experiments represented in panel (A) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition shown. (C) HeLa cells and txnip knockout equivalents (clone 2) stably expressing GLUT1-GFP (green) were cultured as indicated in (A) then fixed for immunofluorescence detection of LAMP1 (red), a marker of lysosomal compartments. (D) Quantification of the experiments represented in panel (C) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition shown. (E) Schematic representation of TXNIP illustrating the predicted arrestin fold domain (yellow), the clathrin-binding motif (orange), and the two PY motifs (green). (F) Complementation analysis of HeLa cells stably expressing GLUT1-GFP (green) with the txnip gene knocked out via CRISPR/Cas9. The knockout cells were stably transfected with either an empty vector or a vector expressing wild-type TXNIP, a clathrin-binding mutant ( cb ), or a py motif mutant ( py ) expressed from a doxycycline-inducible promoter. Cells were cultured as indicated in Figure 1 D with doxycycline added the last 24 h to induce expression of the indicated protein. Cells were fixed and imaged by immunofluorescence for detection of LAMP1 (red), a marker of lysosomal compartments. (G) Quantification of the results shown in panel (F) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) for each condition indicated. The dashed line and area shaded in red indicate the average Pearson’s coefficient and standard deviation (respectively) for the condition in which there is no glucose and TXNIP expression is not induced. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. All measurements of Pearson coefficient of correlation were performed using Softworx software. " width="100%" height="100%">

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: The clathrin-binding motif and PY motifs of TXNIP are required for glucose-mediated GLUT1 trafficking to lysosomes (A) HeLa cells stably expressing a doxycycline-inducible expression vector were cultured using the conditions described in Figure 1 D and, for the induced samples, additionally treated with 1 μg/ml doxycycline for the last 24 h before fixation. Cells were fixed and imaged for immunofluorescence detection of GLUT1 (green) and LAMP1 (red), a marker of lysosomal compartments. Zoomed images provided in the bottom row correspond to the blue dashed-line inset boxes of the top row. (B) Quantification of the experiments represented in panel (A) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition shown. (C) HeLa cells and txnip knockout equivalents (clone 2) stably expressing GLUT1-GFP (green) were cultured as indicated in (A) then fixed for immunofluorescence detection of LAMP1 (red), a marker of lysosomal compartments. (D) Quantification of the experiments represented in panel (C) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition shown. (E) Schematic representation of TXNIP illustrating the predicted arrestin fold domain (yellow), the clathrin-binding motif (orange), and the two PY motifs (green). (F) Complementation analysis of HeLa cells stably expressing GLUT1-GFP (green) with the txnip gene knocked out via CRISPR/Cas9. The knockout cells were stably transfected with either an empty vector or a vector expressing wild-type TXNIP, a clathrin-binding mutant ( cb ), or a py motif mutant ( py ) expressed from a doxycycline-inducible promoter. Cells were cultured as indicated in Figure 1 D with doxycycline added the last 24 h to induce expression of the indicated protein. Cells were fixed and imaged by immunofluorescence for detection of LAMP1 (red), a marker of lysosomal compartments. (G) Quantification of the results shown in panel (F) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) for each condition indicated. The dashed line and area shaded in red indicate the average Pearson’s coefficient and standard deviation (respectively) for the condition in which there is no glucose and TXNIP expression is not induced. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. All measurements of Pearson coefficient of correlation were performed using Softworx software.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Binding Assay, Stable Transfection, Expressing, Plasmid Preparation, Cell Culture, Immunofluorescence, Marker, Knock-Out, CRISPR, Transfection, Mutagenesis, Standard Deviation, Software

TXNIP is dispensable for GLUT1 ubiquitin modification (A) HeLa cells stably expressing GLUT1-GFP were stably transfected with either empty vector (pINDUCER20) or vector expressing wild type, clathrin-binding mutant ( cb ), or py motif mutant (py) TXNIP under the control of Tet-on gene expression system. 1 μg/ml doxycycline was added to induce expression of TXNIP for 24 h prior to collection of cell lysate. Cell lysates were incubated with recombinant WWP1-FLAG at 4 ° C overnight then WWP1-FLAG was pulled down using αFLAG magnetic beads. Elution was performed using FLAG peptide. Lysates and eluates were resolved by SDS-PAGE and analyzed by immunoblot. Immunoblotting of GAPDH was performed as a loading control. (B) HeLa cells stably expressing GLUT1-GFP were transiently transfected with either a wild type or py mutant TXNIP-FLAG expression plasmid. When cells reached 100% confluence, they were collected in lysis buffer and incubated with αFLAG magnetic beads for 1 h at 4 ° C with rotation. TXNIP-FLAG was eluted with FLAG peptide and samples were resolved by SDS-PAGE then analyzed by immunoblot. GAPDH was used as a loading control. (C) HeLa cells stably expressing GLUT1-GFP and a dox-inducible clathrin-binding mutant TXNIP were transiently transfected with either wild-type WWP1-FLAG or a mutant WWP1-FLAG with all 4 ww domains mutated. TXNIP CB was induced with 1 μg/ml doxycycline 24 h before collecting lysates. Cells were then collected in lysis buffer and lysates were incubated with αFLAG magnetic beads for 1 h at 4 ° C with rotation. WWP1 was eluted using FLAG peptide and samples were resolved by SDS-PAGE and analyzed by immunoblot. GAPDH was used as a loading control. (D) HEK293T cells stably expressing FLAG-Ub were split into either 1) regular 25 mM glucose DMEM media, 2) DMEM media with no glucose, or 3) no glucose DMEM media and switched to 25 mM glucose media 2 h before collection. All cells were transiently transfected with a GLUT1-GFP expression plasmid. When cells reached 100% confluency, sample 3 cells were switched to high glucose (25 mM) DMEM media and lysates were collected 2 h later then incubated with magnetic FLAG affinity beads for 1 h at 4 ° C with rotation. FLAG-Ub was eluted using FLAG peptide; samples were resolved by SDS-PAGE, and analyzed by immunoblot. α-Tubulin was used as a loading control. (E) Quantification of the eluate GLUT1 signal for three biological replicates (n = 3) of the experiment shown in (D). ∗∗ indicates a significant difference (p < 0.05) compared to the no glucose condition (lane 2). (F) txnip knockout HeLa cells stably expressing constitutive GLUT1-FLAG and a dox-inducible TXNIP expression plasmid were transiently transfected with HA-Ub. 24 hours before collecting lysates, cells were either mock-treated (sample 2) or treated with 1 µg/ml doxycycline (sample 3) to induce TXNIP expression. As a control, HeLa cells with a stably integrated empty vector (i.e., endogenous TXNIP but no GLUT1-FLAG expression) were also analyzed (sample 1). Lysates were incubated with magnetic αFLAG affinity beads for 1 h at 4°C with rotation and eluted using FLAG peptide. Samples were resolved by SDS-PAGE and analyzed by immunoblot. GAPDH was used as a loading control. (G) Quantification of the eluate HA-Ub signal in four biological replicates (n = 4) of the experiment shown in (F). (H) HeLa cells stably expressing constitutive GLUT1-FLAG and dox-inducible TXNIP vectors were transiently transfected with either empty vector, HA-Ub, and/or WWP1 as indicated in the figure. 24 hours after inducing TXNIP with 1 μg/ml doxycyxline, cells were collected and lysed. Lysates were incubated with magnetic αFLAG affinity beads for 1 h at 4 ° C with rotation. GLUT1-FLAG was eluted with FLAG peptide and samples were resolved by SDS-PAGE then analyzed by immunoblot. GAPDH was used as a loading control. (I) Quantification of HA-Ub signal for at least three biological replicates (n ≥ 3) of the experiments shown in (H). Double asterisk (∗∗) indicates a significant difference (p < 0.05) compared to the empty vector control. All p-values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: TXNIP is dispensable for GLUT1 ubiquitin modification (A) HeLa cells stably expressing GLUT1-GFP were stably transfected with either empty vector (pINDUCER20) or vector expressing wild type, clathrin-binding mutant ( cb ), or py motif mutant (py) TXNIP under the control of Tet-on gene expression system. 1 μg/ml doxycycline was added to induce expression of TXNIP for 24 h prior to collection of cell lysate. Cell lysates were incubated with recombinant WWP1-FLAG at 4 ° C overnight then WWP1-FLAG was pulled down using αFLAG magnetic beads. Elution was performed using FLAG peptide. Lysates and eluates were resolved by SDS-PAGE and analyzed by immunoblot. Immunoblotting of GAPDH was performed as a loading control. (B) HeLa cells stably expressing GLUT1-GFP were transiently transfected with either a wild type or py mutant TXNIP-FLAG expression plasmid. When cells reached 100% confluence, they were collected in lysis buffer and incubated with αFLAG magnetic beads for 1 h at 4 ° C with rotation. TXNIP-FLAG was eluted with FLAG peptide and samples were resolved by SDS-PAGE then analyzed by immunoblot. GAPDH was used as a loading control. (C) HeLa cells stably expressing GLUT1-GFP and a dox-inducible clathrin-binding mutant TXNIP were transiently transfected with either wild-type WWP1-FLAG or a mutant WWP1-FLAG with all 4 ww domains mutated. TXNIP CB was induced with 1 μg/ml doxycycline 24 h before collecting lysates. Cells were then collected in lysis buffer and lysates were incubated with αFLAG magnetic beads for 1 h at 4 ° C with rotation. WWP1 was eluted using FLAG peptide and samples were resolved by SDS-PAGE and analyzed by immunoblot. GAPDH was used as a loading control. (D) HEK293T cells stably expressing FLAG-Ub were split into either 1) regular 25 mM glucose DMEM media, 2) DMEM media with no glucose, or 3) no glucose DMEM media and switched to 25 mM glucose media 2 h before collection. All cells were transiently transfected with a GLUT1-GFP expression plasmid. When cells reached 100% confluency, sample 3 cells were switched to high glucose (25 mM) DMEM media and lysates were collected 2 h later then incubated with magnetic FLAG affinity beads for 1 h at 4 ° C with rotation. FLAG-Ub was eluted using FLAG peptide; samples were resolved by SDS-PAGE, and analyzed by immunoblot. α-Tubulin was used as a loading control. (E) Quantification of the eluate GLUT1 signal for three biological replicates (n = 3) of the experiment shown in (D). ∗∗ indicates a significant difference (p < 0.05) compared to the no glucose condition (lane 2). (F) txnip knockout HeLa cells stably expressing constitutive GLUT1-FLAG and a dox-inducible TXNIP expression plasmid were transiently transfected with HA-Ub. 24 hours before collecting lysates, cells were either mock-treated (sample 2) or treated with 1 µg/ml doxycycline (sample 3) to induce TXNIP expression. As a control, HeLa cells with a stably integrated empty vector (i.e., endogenous TXNIP but no GLUT1-FLAG expression) were also analyzed (sample 1). Lysates were incubated with magnetic αFLAG affinity beads for 1 h at 4°C with rotation and eluted using FLAG peptide. Samples were resolved by SDS-PAGE and analyzed by immunoblot. GAPDH was used as a loading control. (G) Quantification of the eluate HA-Ub signal in four biological replicates (n = 4) of the experiment shown in (F). (H) HeLa cells stably expressing constitutive GLUT1-FLAG and dox-inducible TXNIP vectors were transiently transfected with either empty vector, HA-Ub, and/or WWP1 as indicated in the figure. 24 hours after inducing TXNIP with 1 μg/ml doxycyxline, cells were collected and lysed. Lysates were incubated with magnetic αFLAG affinity beads for 1 h at 4 ° C with rotation. GLUT1-FLAG was eluted with FLAG peptide and samples were resolved by SDS-PAGE then analyzed by immunoblot. GAPDH was used as a loading control. (I) Quantification of HA-Ub signal for at least three biological replicates (n ≥ 3) of the experiments shown in (H). Double asterisk (∗∗) indicates a significant difference (p < 0.05) compared to the empty vector control. All p-values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Ubiquitin Proteomics, Modification, Stable Transfection, Expressing, Transfection, Plasmid Preparation, Binding Assay, Mutagenesis, Control, Gene Expression, Incubation, Recombinant, Magnetic Beads, SDS Page, Western Blot, Lysis, Knock-Out

Mapping of cytosolic lysines required for lysosomal trafficking of GLUT1 (A) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R) were cultured in media lacking glucose for 24 h then cultured for another 24 h in fresh media lacking glucose (“no glucose”) or shifted to fresh media with high glucose (25 mM) for 24 h (“high glucose”) prior to fixation and imaging for immunofluorescence detection of LAMP1 (red). Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (B) Quantification of the results shown in (A) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. ∗∗ indicates p < 1x10 -5 . (C) Schematic of GLUT1 illustrating the primary amino acid sequence of N-terminal and C-terminal cytosolic tails. Lysine residues in the N-terminal and C-terminal cytosolic tails are highlighted in red. A similar schematic illustrating the lysine residues in the major cytosolic loop is shown in <xref ref-type=Figure S11 B. (D) HeLa cells stably expressing either wild-type GLUT1-GFP, GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R), GLUT1-GFP with the 6 lysines on the major cytosolic loop mutated to arginine (6K loop →R ), or GLUT1-GFP with the 5 cytosolic lysines outside of the major loop mutated to arginine (5K tails →R) were cultured as in (A) prior to fixation and imaging for immunofluorescence detection of LAMP1 (red). Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (E) Quantification of the results shown in panel D was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. The dashed line and area shaded in red indicate the average Pearson’s coefficient and standard deviation for the WT GLUT1-GFP co-localization with LAMP1 under glucose-starved conditions. All measurements of Pearson coefficient of correlation were performed using Softworx software. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. " width="100%" height="100%">

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: Mapping of cytosolic lysines required for lysosomal trafficking of GLUT1 (A) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R) were cultured in media lacking glucose for 24 h then cultured for another 24 h in fresh media lacking glucose (“no glucose”) or shifted to fresh media with high glucose (25 mM) for 24 h (“high glucose”) prior to fixation and imaging for immunofluorescence detection of LAMP1 (red). Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (B) Quantification of the results shown in (A) was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. ∗∗ indicates p < 1x10 -5 . (C) Schematic of GLUT1 illustrating the primary amino acid sequence of N-terminal and C-terminal cytosolic tails. Lysine residues in the N-terminal and C-terminal cytosolic tails are highlighted in red. A similar schematic illustrating the lysine residues in the major cytosolic loop is shown in Figure S11 B. (D) HeLa cells stably expressing either wild-type GLUT1-GFP, GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R), GLUT1-GFP with the 6 lysines on the major cytosolic loop mutated to arginine (6K loop →R ), or GLUT1-GFP with the 5 cytosolic lysines outside of the major loop mutated to arginine (5K tails →R) were cultured as in (A) prior to fixation and imaging for immunofluorescence detection of LAMP1 (red). Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (E) Quantification of the results shown in panel D was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. The dashed line and area shaded in red indicate the average Pearson’s coefficient and standard deviation for the WT GLUT1-GFP co-localization with LAMP1 under glucose-starved conditions. All measurements of Pearson coefficient of correlation were performed using Softworx software. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Stable Transfection, Expressing, Cell Culture, Imaging, Immunofluorescence, Sequencing, Standard Deviation, Software

TXNIP-mediated trafficking of GLUT1 requires its cytosolic lysine residues (A) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R) were stably transfected with a doxycycline-inducible vector harboring wild-type TXNIP. Cells were cultured as indicated in <xref ref-type=Figure 1 D prior to fixation and imaging for immunofluorescence detection of LAMP1 (red), a marker of lysosomal compartments. Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (B) Quantification of the results shown in panel A was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. (C) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R GLUT1) were stably transfected with a doxycyclin-inducible vector harboring wild-type TXNIP. Cells were cultured as indicated in Figure 1 D. Prior to imaging, cells were placed on ice and switched to cold (4°C) buffer containing the lipophilic tracer dye FM4-64 (8 μM) (red) in order to label the plasma membrane. Live cells were imaged in cold buffer immediately to ensure retention of FM4-64 at the plasma membrane. Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (D) Quantification of the results shown in panel C was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. All measurements of Pearson coefficient of correlation were performed using Softworx software. " width="100%" height="100%">

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet: TXNIP-mediated trafficking of GLUT1 requires its cytosolic lysine residues (A) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R) were stably transfected with a doxycycline-inducible vector harboring wild-type TXNIP. Cells were cultured as indicated in Figure 1 D prior to fixation and imaging for immunofluorescence detection of LAMP1 (red), a marker of lysosomal compartments. Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (B) Quantification of the results shown in panel A was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. (C) HeLa cells stably expressing either wild-type GLUT1-GFP or GLUT1-GFP with all cytosolic lysines mutated to arginine (11K cyto →R GLUT1) were stably transfected with a doxycyclin-inducible vector harboring wild-type TXNIP. Cells were cultured as indicated in Figure 1 D. Prior to imaging, cells were placed on ice and switched to cold (4°C) buffer containing the lipophilic tracer dye FM4-64 (8 μM) (red) in order to label the plasma membrane. Live cells were imaged in cold buffer immediately to ensure retention of FM4-64 at the plasma membrane. Zoomed images in the bottom row correspond to the blue dashed line inset boxes of the image above. (D) Quantification of the results shown in panel C was performed by measuring the Pearson coefficient of correlation for 30 cells (n = 30) with each condition indicated. All p values were measured using a two sample Student’s t-Test in Microsoft Excel. A P value < 0.05 was considered statistically significant and is indicated by ∗∗. Data are represented as mean +/- SEM. All measurements of Pearson coefficient of correlation were performed using Softworx software.

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Stable Transfection, Expressing, Transfection, Plasmid Preparation, Cell Culture, Imaging, Immunofluorescence, Marker, Clinical Proteomics, Membrane, Software

Journal: iScience

Article Title: Lysosomal trafficking of the glucose transporter GLUT1 requires sequential regulation by TXNIP and ubiquitin

doi: 10.1016/j.isci.2023.106150

Figure Lengend Snippet:

Article Snippet: GLUT1 antibody , Proteintech , Proteintech Cat# 21829-1-AP, RRID: AB_10837075.

Techniques: Purification, Produced, Recombinant, Infection, Stable Transfection, Expressing, Diagnostic Assay, CRISPR, Plasmid Preparation, Software

Phospholipids analysis of HepG2 and HepG2.2.15 cells. ( A ) OPLS-DA scores plots showing the separation between HepG2 and HepG2.2.15 cells, Q 2 = 0.902, p = 1.90 × 10 −6 . ( B ) The total amount of each class of phospholipid in cells. ( C ) The significant difference of phospholipids between HepG2 and HepG2.2.15 cells. The significance of the metabolites was used the criteria that variable VIP > 1, p value < 0.05, and fold change > 1.2 or < 0.8. The histogram is expressed as mean ± SD, n = 10, detailed data of phosphatidylcholines are shown in Table . *** p value < 0.001, ** p value < 0.01, * p value < 0.05.

Journal: Scientific Reports

Article Title: Stimulated phospholipid synthesis is key for hepatitis B virus replications

doi: 10.1038/s41598-019-49367-8

Figure Lengend Snippet: Phospholipids analysis of HepG2 and HepG2.2.15 cells. ( A ) OPLS-DA scores plots showing the separation between HepG2 and HepG2.2.15 cells, Q 2 = 0.902, p = 1.90 × 10 −6 . ( B ) The total amount of each class of phospholipid in cells. ( C ) The significant difference of phospholipids between HepG2 and HepG2.2.15 cells. The significance of the metabolites was used the criteria that variable VIP > 1, p value < 0.05, and fold change > 1.2 or < 0.8. The histogram is expressed as mean ± SD, n = 10, detailed data of phosphatidylcholines are shown in Table . *** p value < 0.001, ** p value < 0.01, * p value < 0.05.

Article Snippet: The human hepatoblastoma cell line HepG2 and HepG2.2.15 cells (with stable expression and replication of HBV) were purchased from China Center for Type Culture Collection (CCTCC, Wuhan, China).

Techniques:

The relative mRNA expression levels of major genes in PC synthesis and metabolic pathways. ( A ) Phosphatidylcholine synthesis and metabolism pathways. ( B ) The relative mRNA level of major genes in phosphatidylcholine synthesis and metabolism in HepG2 and HepG2.2.15 cells, n = 3, detailed data are shown in Table . ( C ) The western blot analysis of LPP1, PCYT1A protein expression levels in HepG2 and HepG2.2.15 cells, the initial figure is shown in Fig. . ( D ) The levels of the substrates of the PC synthesis in HepG2 and HepG2.2.15 cells, n = 10. ( B , D ) data are shown as mean ± SD, t-test, *** p value < 0.001, ** p value < 0.01, * p value < 0.05. PA: phos p hatidic acid, DAG: diglyceride, PC: phosphatidylcholine, PE: phosphatidylethanolamine, PS: phosphatidylserine, LPC: lyso-phosphatidylcholine, GPC: glycerol-phosphorylcholine.

Journal: Scientific Reports

Article Title: Stimulated phospholipid synthesis is key for hepatitis B virus replications

doi: 10.1038/s41598-019-49367-8

Figure Lengend Snippet: The relative mRNA expression levels of major genes in PC synthesis and metabolic pathways. ( A ) Phosphatidylcholine synthesis and metabolism pathways. ( B ) The relative mRNA level of major genes in phosphatidylcholine synthesis and metabolism in HepG2 and HepG2.2.15 cells, n = 3, detailed data are shown in Table . ( C ) The western blot analysis of LPP1, PCYT1A protein expression levels in HepG2 and HepG2.2.15 cells, the initial figure is shown in Fig. . ( D ) The levels of the substrates of the PC synthesis in HepG2 and HepG2.2.15 cells, n = 10. ( B , D ) data are shown as mean ± SD, t-test, *** p value < 0.001, ** p value < 0.01, * p value < 0.05. PA: phos p hatidic acid, DAG: diglyceride, PC: phosphatidylcholine, PE: phosphatidylethanolamine, PS: phosphatidylserine, LPC: lyso-phosphatidylcholine, GPC: glycerol-phosphorylcholine.

Article Snippet: The human hepatoblastoma cell line HepG2 and HepG2.2.15 cells (with stable expression and replication of HBV) were purchased from China Center for Type Culture Collection (CCTCC, Wuhan, China).

Techniques: Expressing, Western Blot

HepG2.2.15 cells were transfected by siRNA. ( A ) The framework of gene silencing with siRNA. ( B ) The relative mRNA levels of PCYT1A and LPP1 . ( C ) The western blot analysis of LPP1, PCYT1A protein expression levels in the siRNA negative control group and treatment group, the initial figure is shown in Fig. . ( D ) The relative levels of HBsAg. ( E ) The relative levels of HBeAg. ( F ) The relative levels of HBV DNA. ( G ) The proliferation of HepG2.2.15 cells transfected by siRNA was assayed using cell-counting assay. ( B , D – F ) data are shown as mean ± SD, n = 3, t-test *** p value < 0.001, ** p value < 0.01, * p value < 0.05. PA: phos p hatidic acid, DAG: diglyceride, PC: phosphatidylcholine. siRNA: si PCYT1A or si LPP1 , siNC: negative control siRNA.

Journal: Scientific Reports

Article Title: Stimulated phospholipid synthesis is key for hepatitis B virus replications

doi: 10.1038/s41598-019-49367-8

Figure Lengend Snippet: HepG2.2.15 cells were transfected by siRNA. ( A ) The framework of gene silencing with siRNA. ( B ) The relative mRNA levels of PCYT1A and LPP1 . ( C ) The western blot analysis of LPP1, PCYT1A protein expression levels in the siRNA negative control group and treatment group, the initial figure is shown in Fig. . ( D ) The relative levels of HBsAg. ( E ) The relative levels of HBeAg. ( F ) The relative levels of HBV DNA. ( G ) The proliferation of HepG2.2.15 cells transfected by siRNA was assayed using cell-counting assay. ( B , D – F ) data are shown as mean ± SD, n = 3, t-test *** p value < 0.001, ** p value < 0.01, * p value < 0.05. PA: phos p hatidic acid, DAG: diglyceride, PC: phosphatidylcholine. siRNA: si PCYT1A or si LPP1 , siNC: negative control siRNA.

Article Snippet: The human hepatoblastoma cell line HepG2 and HepG2.2.15 cells (with stable expression and replication of HBV) were purchased from China Center for Type Culture Collection (CCTCC, Wuhan, China).

Techniques: Transfection, Western Blot, Expressing, Negative Control, Cell Counting

Lys 154 is the major Dex-induced acetylation site (A) Western blot analysis with pan acetyl-lysine (ac-K) detecting acetylation levels of the FLAG-tagged GR-wild-type (WT) or Lys to Arg mutants of the individual AF-1 acetylation sites, all three (τ1-KR), and all seven residues in the NTD (7KR), immunoprecipitated from BHK-21 cells that were treated with vehicle or 1 μM Dex for 6 h. (B) Scheme indicating position of the acetylated lysines in the N-terminal domain of hGR. Lys 154 is marked in red and its conservation among murine, rat, bovine and human GR is shown in the multiple sequence alignment below. Color scheme indicating amino acid properties and consensus symbols is as outlined by CLUSTAL Omega. (C) Western blot detection of global GR acetylation with pan acetyl-lysine antibody or GR-K154 acetylation with the site-specific anti-acK154 antibodies in FLAG immunoprecipitates (top:IP) and whole cell lysates (bottom) prepared from HEK293 GR −/− cells transiently expressing wild-type or mutant FLAG-GR and treated with vehicle or 1 μM Dex for 6 h. (D) Western blot monitoring endogenous GR-K154 acetylation in lysates from vehicle or Dex (1 μM, 6 h) treated human (HepG2, A549 and HeLa), primary human umbilical vein endothelial cells (HUVEC) and mouse fibroblast (NIH3T3) cell lines. Beta actin (ACTB) served as loading control. (E) Western blot analysis of GR-K154 acetylation in tissue lysates derived from liver, lung and spleen of C57BL/6 mice treated with vehicle or 1 mg/kg Dex (i.p) for 6 h. Vinculin (VCL) served as loading control. (F) Immunoblot of GR-K154 acetylation in vehicle- or Dex- (1 μM, 6 h) treated HepG2 cells that were co-treated with DMSO (as control), 20 μM Ex527 or 5 μM A485 respectively. (G) Ratios of acK154 to GR western blot signals from (F) were quantified and normalized to Dex+DMSO sample and represented as relative acK154/GR (Mean ± S.E.M; n = 3 independent experiments, ∗p < 0.05, ∗∗p < 0.01; Welch’s t-test). See also <xref ref-type=Figure S2 . " width="100%" height="100%">

Journal: iScience

Article Title: Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling

doi: 10.1016/j.isci.2024.108943

Figure Lengend Snippet: Lys 154 is the major Dex-induced acetylation site (A) Western blot analysis with pan acetyl-lysine (ac-K) detecting acetylation levels of the FLAG-tagged GR-wild-type (WT) or Lys to Arg mutants of the individual AF-1 acetylation sites, all three (τ1-KR), and all seven residues in the NTD (7KR), immunoprecipitated from BHK-21 cells that were treated with vehicle or 1 μM Dex for 6 h. (B) Scheme indicating position of the acetylated lysines in the N-terminal domain of hGR. Lys 154 is marked in red and its conservation among murine, rat, bovine and human GR is shown in the multiple sequence alignment below. Color scheme indicating amino acid properties and consensus symbols is as outlined by CLUSTAL Omega. (C) Western blot detection of global GR acetylation with pan acetyl-lysine antibody or GR-K154 acetylation with the site-specific anti-acK154 antibodies in FLAG immunoprecipitates (top:IP) and whole cell lysates (bottom) prepared from HEK293 GR −/− cells transiently expressing wild-type or mutant FLAG-GR and treated with vehicle or 1 μM Dex for 6 h. (D) Western blot monitoring endogenous GR-K154 acetylation in lysates from vehicle or Dex (1 μM, 6 h) treated human (HepG2, A549 and HeLa), primary human umbilical vein endothelial cells (HUVEC) and mouse fibroblast (NIH3T3) cell lines. Beta actin (ACTB) served as loading control. (E) Western blot analysis of GR-K154 acetylation in tissue lysates derived from liver, lung and spleen of C57BL/6 mice treated with vehicle or 1 mg/kg Dex (i.p) for 6 h. Vinculin (VCL) served as loading control. (F) Immunoblot of GR-K154 acetylation in vehicle- or Dex- (1 μM, 6 h) treated HepG2 cells that were co-treated with DMSO (as control), 20 μM Ex527 or 5 μM A485 respectively. (G) Ratios of acK154 to GR western blot signals from (F) were quantified and normalized to Dex+DMSO sample and represented as relative acK154/GR (Mean ± S.E.M; n = 3 independent experiments, ∗p < 0.05, ∗∗p < 0.01; Welch’s t-test). See also Figure S2 .

Article Snippet: HepG2 GR -/- cells were transfected with pLenti6-UBC-mSLC7A1 (Addgene #17224) to transiently express ecotropic receptor protein mSLC7A1 (mCAT1) and transduced with pseudotyped lentiviral pCW57-MCS1-2A-MCS2 vector (Addgene #71782) harboring Ty1-tagged human NR3C1 wildtype or mutant cDNA.

Techniques: Western Blot, Immunoprecipitation, Sequencing, Expressing, Mutagenesis, Control, Derivative Assay

Lys 154 acetylation is agonist-dependent and correlates with GR activation (A) RT-qPCR analysis of GILZ expression levels in HepG2 cells treated with vehicle or 1 μM each of Dex or prednisolone (Pred) or hydrocortisone (Hydro) respectively for 6 h. (B) Western blot detection of GR-K154 acetylation in cells treated as in (A). (C) Subcellular fractionation showing distribution of GR-K154 acetylation, GR and bona fide cytoplasmic (C) and nuclear (N) markers alpha-tubulin (TUBA) and lamin A/C (LMNA/C) respectively in fractions of HepG2 cells that were treated with vehicle or 1 μM each of Dex or RU486 for 6 h. (D) RT-qPCR analysis of GILZ expression levels in HepG2 cells treated with vehicle or 1 μM each of Dex, RU486 or both, for 6 h. (E) Western blot image of GR-K154 acetylation in whole cell lysates from HepG2 cells treated as in (D). (F) Western blot analysis of GR-K154 acetylation in whole cell lysates (top panel) or histone acetylation with pan-acetyl lysine antibody in histone preparations (bottom panel). HepG2 cells were treated with vehicle or 1 μM each of Dex or RU486 with 20 μM Ex527 or 1 μM TSA, respectively for 6 h. TUBA and histone H3 serve as respective loading controls. (G) RT-qPCR of GILZ mRNA in cells treated with Pol II inhibitor, flavopiridol (1 μM) in combination with vehicle or 1 μM Dex for 6 h. (H) Western blot monitoring the effect of transcription inhibition on GR-K154 acetylation in HepG2 cells treated as in (G). Quantification is shown in the graph on the right. (I) Western blot image showing GR-K154 acetylation of GFP-tagged mGR wild-type (WT) or monomeric (mon) or tetrameric (tetra) mutants (indicated in the scheme in the top panel) transiently expressed in HEK293 GR −/− cells treated with vehicle or 1 μM Dex for 6 h. Quantification is shown in the graph on the right. Data in (H) and (I) represent ratios of acK154 to GR western blot signals normalized to the Dex alone (H) or to the WT-Dex (I) sample and represented as relative acK154/GR in the graphs on the right. n = 3 independent experiments; Welch’s t-test, ∗p < 0.05, n.s: non-significant. Data in (A), (D) and (G) represent mean of log2 fold change values from n = 3 independent experiments. Error bars = S.E.M. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n.s = non-significant; One-way ANOVA-Fischer’s LSD test. See also <xref ref-type=Figure S3 . " width="100%" height="100%">

Journal: iScience

Article Title: Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling

doi: 10.1016/j.isci.2024.108943

Figure Lengend Snippet: Lys 154 acetylation is agonist-dependent and correlates with GR activation (A) RT-qPCR analysis of GILZ expression levels in HepG2 cells treated with vehicle or 1 μM each of Dex or prednisolone (Pred) or hydrocortisone (Hydro) respectively for 6 h. (B) Western blot detection of GR-K154 acetylation in cells treated as in (A). (C) Subcellular fractionation showing distribution of GR-K154 acetylation, GR and bona fide cytoplasmic (C) and nuclear (N) markers alpha-tubulin (TUBA) and lamin A/C (LMNA/C) respectively in fractions of HepG2 cells that were treated with vehicle or 1 μM each of Dex or RU486 for 6 h. (D) RT-qPCR analysis of GILZ expression levels in HepG2 cells treated with vehicle or 1 μM each of Dex, RU486 or both, for 6 h. (E) Western blot image of GR-K154 acetylation in whole cell lysates from HepG2 cells treated as in (D). (F) Western blot analysis of GR-K154 acetylation in whole cell lysates (top panel) or histone acetylation with pan-acetyl lysine antibody in histone preparations (bottom panel). HepG2 cells were treated with vehicle or 1 μM each of Dex or RU486 with 20 μM Ex527 or 1 μM TSA, respectively for 6 h. TUBA and histone H3 serve as respective loading controls. (G) RT-qPCR of GILZ mRNA in cells treated with Pol II inhibitor, flavopiridol (1 μM) in combination with vehicle or 1 μM Dex for 6 h. (H) Western blot monitoring the effect of transcription inhibition on GR-K154 acetylation in HepG2 cells treated as in (G). Quantification is shown in the graph on the right. (I) Western blot image showing GR-K154 acetylation of GFP-tagged mGR wild-type (WT) or monomeric (mon) or tetrameric (tetra) mutants (indicated in the scheme in the top panel) transiently expressed in HEK293 GR −/− cells treated with vehicle or 1 μM Dex for 6 h. Quantification is shown in the graph on the right. Data in (H) and (I) represent ratios of acK154 to GR western blot signals normalized to the Dex alone (H) or to the WT-Dex (I) sample and represented as relative acK154/GR in the graphs on the right. n = 3 independent experiments; Welch’s t-test, ∗p < 0.05, n.s: non-significant. Data in (A), (D) and (G) represent mean of log2 fold change values from n = 3 independent experiments. Error bars = S.E.M. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n.s = non-significant; One-way ANOVA-Fischer’s LSD test. See also Figure S3 .

Article Snippet: HepG2 GR -/- cells were transfected with pLenti6-UBC-mSLC7A1 (Addgene #17224) to transiently express ecotropic receptor protein mSLC7A1 (mCAT1) and transduced with pseudotyped lentiviral pCW57-MCS1-2A-MCS2 vector (Addgene #71782) harboring Ty1-tagged human NR3C1 wildtype or mutant cDNA.

Techniques: Activation Assay, Quantitative RT-PCR, Expressing, Western Blot, Fractionation, Inhibition

Acetylation-deficient GR sustains transcription longer than the wild-type (A) Western blot showing doxycycline-induced expression of wild-type and mutant GR in stably transduced HepG2 GR −/− cells treated with vehicle or 1 μM Dex for 6 h. Quantification below shows relative GR/ACTB levels normalized to WT veh sample from n = 4 independent experiments. n.s = non-significant; Welch’s ANOVA with Dunnett’s T3 post hoc test. (B) Luciferase assay detecting MMTV-driven luciferase expression in cells treated as in (A) expressed as fold induction to respective vehicle controls. (C) ChEA3 analysis of the 100 commonly regulated DEGs showing top 10 enriched transcription factors (TFs). Y axis shows names of TFs and X axis indicates negative logarithm of Fischer’s exact test (FET) p-values. (D) Gene ontology analysis indicating biological processes enriched among the common DEGs. (E) Heatmap showing expression of all Dex-regulated genes common between WT-, K154R- and K154Q-GR mutants as identified by RNA-seq analysis. (F) Western blot showing GR-K154 acetylation, GR and SIRT1 levels in HepG2 cells over a time course of 1 μM Dex treatment (0–24 h). ACTB serves as loading control. (G) Ratios of acK154 to GR (orange) or GR to ACTB (blue) western blot signals from (F) were quantified and normalized to 24 h Dex sample or vehicle (0 h Dex) sample respectively and represented as relative signal. (H) RT-qPCR showing expression of GILZ as log2 fold change in cells treated as in (F). (I) RT-qPCR showing expression of GILZ as log2 fold change to vehicle after 6 h, 12 h and 24 h Dex treatments in HepG2 GR −/− + WT-GR or HepG2 GR −/− + K154R cell lines. Data represent mean from n = 4, except for (G, H) where n = 3, independent experiments. Error bars = S.E.M ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, n.s = non-significant; One way ANOVA- Fischer’s LSD test (G, H, I). See also <xref ref-type=Figure S4 , Tables S1 and . " width="100%" height="100%">

Journal: iScience

Article Title: Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling

doi: 10.1016/j.isci.2024.108943

Figure Lengend Snippet: Acetylation-deficient GR sustains transcription longer than the wild-type (A) Western blot showing doxycycline-induced expression of wild-type and mutant GR in stably transduced HepG2 GR −/− cells treated with vehicle or 1 μM Dex for 6 h. Quantification below shows relative GR/ACTB levels normalized to WT veh sample from n = 4 independent experiments. n.s = non-significant; Welch’s ANOVA with Dunnett’s T3 post hoc test. (B) Luciferase assay detecting MMTV-driven luciferase expression in cells treated as in (A) expressed as fold induction to respective vehicle controls. (C) ChEA3 analysis of the 100 commonly regulated DEGs showing top 10 enriched transcription factors (TFs). Y axis shows names of TFs and X axis indicates negative logarithm of Fischer’s exact test (FET) p-values. (D) Gene ontology analysis indicating biological processes enriched among the common DEGs. (E) Heatmap showing expression of all Dex-regulated genes common between WT-, K154R- and K154Q-GR mutants as identified by RNA-seq analysis. (F) Western blot showing GR-K154 acetylation, GR and SIRT1 levels in HepG2 cells over a time course of 1 μM Dex treatment (0–24 h). ACTB serves as loading control. (G) Ratios of acK154 to GR (orange) or GR to ACTB (blue) western blot signals from (F) were quantified and normalized to 24 h Dex sample or vehicle (0 h Dex) sample respectively and represented as relative signal. (H) RT-qPCR showing expression of GILZ as log2 fold change in cells treated as in (F). (I) RT-qPCR showing expression of GILZ as log2 fold change to vehicle after 6 h, 12 h and 24 h Dex treatments in HepG2 GR −/− + WT-GR or HepG2 GR −/− + K154R cell lines. Data represent mean from n = 4, except for (G, H) where n = 3, independent experiments. Error bars = S.E.M ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001, n.s = non-significant; One way ANOVA- Fischer’s LSD test (G, H, I). See also Figure S4 , Tables S1 and .

Article Snippet: HepG2 GR -/- cells were transfected with pLenti6-UBC-mSLC7A1 (Addgene #17224) to transiently express ecotropic receptor protein mSLC7A1 (mCAT1) and transduced with pseudotyped lentiviral pCW57-MCS1-2A-MCS2 vector (Addgene #71782) harboring Ty1-tagged human NR3C1 wildtype or mutant cDNA.

Techniques: Western Blot, Expressing, Mutagenesis, Stable Transfection, Luciferase, RNA Sequencing, Control, Quantitative RT-PCR

GR acetylation attenuates chromatin binding and protein stability upon prolonged GC exposure (A) ChIP-qPCR showing GILZ (Gene name: TSC22D3 ) and FKBP5 GRE occupancy of GR in HepG2 GR −/− + WT-GR and HepG2 GR −/− + K154R cells treated with vehicle or 1 μM Dex for 24 h. Scheme above shows qPCR amplicon positions for GILZ (purple) and FKBP5 (orange) GRE with respect to GR ChIP-seq peaks in HepG2 cells from. Data are shown as percentage of input. IgG served as a control for ChIP background. (B) Western blot analysis of CHX chase experiment. HepG2 GR −/− cells transiently overexpressing Ty1-tagged WT or K154R-GR were treated with 1 μM Dex for 2 h followed by 20 ng/mL CHX for the indicated durations. Quantification shows GR/ACTB ratios normalized to respective 0 h CHX control. (C) CHX chase experiment as in (B) performed in HepG2 cells treated with 1 μM Dex+DMSO or 1 μM Dex+20 μM Ex527. Quantification shows GR/TUBA ratios normalized to respective 0 h CHX controls. (D) Western blot analysis of polyubiquitinated FLAG-GR immunoprecipitated from HEK239 GR −/− transiently expressing FLAG-tagged WT- or K154R-GR along with HA-UBB, treated with 1 μM Dex with or without 1 μM MG132 for 24 h. Quantification represents ratio of HA-UBB/GR signals from lanes 2 and 4 normalized to WT-Dex+MG132 (lane 2) sample. Data represent mean of n = 3 except for (A) where n = 4 independent experiments. Error bars = S.E.M. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n.s = non-significant; (B, C): One way ANOVA-Fischer’s LSD test; (A) Student’s paired t-test and (D) Welch’s t-test. See also <xref ref-type=Figure S5 A. " width="100%" height="100%">

Journal: iScience

Article Title: Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling

doi: 10.1016/j.isci.2024.108943

Figure Lengend Snippet: GR acetylation attenuates chromatin binding and protein stability upon prolonged GC exposure (A) ChIP-qPCR showing GILZ (Gene name: TSC22D3 ) and FKBP5 GRE occupancy of GR in HepG2 GR −/− + WT-GR and HepG2 GR −/− + K154R cells treated with vehicle or 1 μM Dex for 24 h. Scheme above shows qPCR amplicon positions for GILZ (purple) and FKBP5 (orange) GRE with respect to GR ChIP-seq peaks in HepG2 cells from. Data are shown as percentage of input. IgG served as a control for ChIP background. (B) Western blot analysis of CHX chase experiment. HepG2 GR −/− cells transiently overexpressing Ty1-tagged WT or K154R-GR were treated with 1 μM Dex for 2 h followed by 20 ng/mL CHX for the indicated durations. Quantification shows GR/ACTB ratios normalized to respective 0 h CHX control. (C) CHX chase experiment as in (B) performed in HepG2 cells treated with 1 μM Dex+DMSO or 1 μM Dex+20 μM Ex527. Quantification shows GR/TUBA ratios normalized to respective 0 h CHX controls. (D) Western blot analysis of polyubiquitinated FLAG-GR immunoprecipitated from HEK239 GR −/− transiently expressing FLAG-tagged WT- or K154R-GR along with HA-UBB, treated with 1 μM Dex with or without 1 μM MG132 for 24 h. Quantification represents ratio of HA-UBB/GR signals from lanes 2 and 4 normalized to WT-Dex+MG132 (lane 2) sample. Data represent mean of n = 3 except for (A) where n = 4 independent experiments. Error bars = S.E.M. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, n.s = non-significant; (B, C): One way ANOVA-Fischer’s LSD test; (A) Student’s paired t-test and (D) Welch’s t-test. See also Figure S5 A.

Article Snippet: HepG2 GR -/- cells were transfected with pLenti6-UBC-mSLC7A1 (Addgene #17224) to transiently express ecotropic receptor protein mSLC7A1 (mCAT1) and transduced with pseudotyped lentiviral pCW57-MCS1-2A-MCS2 vector (Addgene #71782) harboring Ty1-tagged human NR3C1 wildtype or mutant cDNA.

Techniques: Binding Assay, ChIP-qPCR, Amplification, ChIP-sequencing, Control, Western Blot, Immunoprecipitation, Expressing

Journal: iScience

Article Title: Acetylation-induced proteasomal degradation of the activated glucocorticoid receptor limits hormonal signaling

doi: 10.1016/j.isci.2024.108943

Figure Lengend Snippet:

Article Snippet: HepG2 GR -/- cells were transfected with pLenti6-UBC-mSLC7A1 (Addgene #17224) to transiently express ecotropic receptor protein mSLC7A1 (mCAT1) and transduced with pseudotyped lentiviral pCW57-MCS1-2A-MCS2 vector (Addgene #71782) harboring Ty1-tagged human NR3C1 wildtype or mutant cDNA.

Techniques: Generated, Recombinant, Cell Culture, Synthesized, Luciferase, RNA Library Preparation, Isolation, Multiplex Assay, Software